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This retrospective audit aimed to highlight the current demands placed on the existing Adult 
Mental Health speciality within the Dumfries and Galloway Psychology service in terms of patient 
and referrer need since the reconfiguration o f service provisions and to detail how the needs are 
currently being met. Specific aims o f this audit were; to examine referral characteristics and 
referral outcomes received during a one-year period (between October 2002 and September 2003), 
examine service utilisation per geographical area, and to highlight differences in referral 
characteristics and referral outcome between geographical area and referring agents. Specific 
referral characteristics examined were: patient characteristics (age and gender) and referring 
problem (primary problem, chronicity, severity and complexity). Discharge forms, completed by 
AMH speciality staff as standard, provided the outcome of each referral, detailing reason for 
discharge, session attendance and subjective clinical judgment o f outcome.
A total number o f 1303 referrals were referred to the speciality within the one-year period. There 
were three major referral agents to the AMH speciality, namely, General Practitioners (GP) 
Community Mental Health Teams (CMHT) and Psychiatric Medical Practitioners (PMP). 
Referrals were sent for a variety of psychological difficulties however one quarter o f referrals were 
primarily experiencing an anxiety disorder (24.9%) and one quarter with a depressive disorder 
(24.6%). Attendance varied across referrals, however there were a high percentage o f referrals 
discharged due to non-attendance (37.8%).
Geographically, referrals did not differ in terms of age, sex, attendance or outcome. They did 
however differ in terms o f severity, complexity, and chronicity o f referral, which may be a 
reflection o f referring agents in different areas or differences in AMH speciality staff rating
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methods. Referrals examined between referral agents did not differ in terms o f age, sex, attendance 
or outcome. They did however differ in terms o f severity, complexity, and chronicity o f referral, 
which may be a reflection of primary and secondary caregivers or differences between AMH 
speciality staff rating methods.
The reliability and validity o f outcome ratings are questionable due to being subjective and not 
calibrated. Discrepancies between outcome frequencies were found and interpretations of data 
were difficult. The need to revise outcome categories, rating procedures, and to implement 
guidelines for rating referral characteristics and outcome categories for AMH speciality staff was 
highlighted, which may reduce future discrepancies between reported data. Staff training to 
enable consistent and appropriate scoring o f discharge forms was recommended. AMH speciality 
staff inter-rater and intra-rater reliability research, with regards to scoring discharge forms, was 
also recommended for the department to undertake.
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Introduction & Aims
Increasing demands placed on clinical psychology services, at a time when financial resources are 
severely limited, highlight the need to identify the most effective and efficient ways o f providing 
such services (Kincey & Creed, 1991). This need is now mandatory within all NHS services due 
to recent government initiatives and legislation that require an evidence-based, high-class service 
through clinical governance (Department of Health, 1998, 1999). Audit has been recognised as one 
method where services can evaluate resources efficiently and effectively (Elliot et al., 1994; 
McPherson et al., 1996). This has resulted in audit becoming an integral and essential process in 
clinical practice in order to improve the quality o f public services. Forsythe & Gallagher (2003) 
define audit as ‘...a  systematic evaluation of a service resulting in improvements in the quality of 
care. It should be a cycle of activity involving systematic review of practice, identification of 
problems, development o f solutions, implementation of change and then review again’.
The Dumfries and Galloway Adult Mental Health (AMH) Psychology Speciality is comprised of 
four teams that are responsible for providing psychological care in a rural setting to four differing 
geographical areas within Dumfries and Galloway NHS Health Board; Annandale & Eskdale 
(AE), Nithsdale & Upper Nithsdale (NU), Stewartry (ST), and Wigtownshire (WG). Each area 
team utilises a wide skill mix in order to provide this care using clinical psychologists, counsellors 
and psychotherapists1.
The speciality has undertaken several clinical audits during recent years due to new developments 
in service provision, initiated with the arrival of the new Director o f Psychological services, and 
the creation o f the clinical governance committee within the department. Developments
1 Throughout this report clinical psychologists, counsellors, and psychotherapists will be referred to ‘AMH 
speciality s ta ff .
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implemented in September 2001, such as a referrer feedback system informing them of client 
waiting times (unpublished document; Hancock, 1999), Dumfries and Galloway Department of 
Psychological Services and Research Development Plan 2002/2003), aimed to increase appropriate 
service utilisation and maximise available resources.
Although audit is a continuous process within the department recent audits have only examined 
specific variables, such as treatment length and outcome at a macro level (unpublished document; 
Mackie, 2003), or have been restricted to specialist services such as the ‘self-help’ project or the 
evaluative therapeutic outcome project, Clinical Outcomes for Routine Evaluation (CORE). Data 
was not available within the department detailing referral characteristics or referral outcomes prior 
to 2001 in order to examine if  the developments had an impact on service utilisation and provision. 
It was therefore deemed necessary to review service provision at present, at macro and micro 
levels, between geographical areas and referring agents in order to have an accurate baseline of 
current service provision.
A review o f this type aims to highlight current demands placed on the existing service in terms of 
patient and referrer need and will detail how that demand is currently being met. This information 
can inform future developments to increase service responsivity through a local needs-led 
approach, thus increasing service efficiency. Specific aims o f this audit are therefore:
■ To examine referral characteristics and referral outcomes received during a one-year period to 
the AMH speciality in the Dumfries and Galloway NHS Health Board.
■ To examine service utilisation per geographical area in terms o f attendance rates.
■ To highlight differences in referral characteristics and referral outcome between geographical 
area and referring agents.
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Methodology
This was a retrospective audit o f referrals received to the AMH speciality during a one-year period 
(to minimise the effects o f seasonal variation) between October 2002 and September 2003. The
thonly exclusion category employed was if  the client had not been discharged by 6 May 2004. Data 
was extracted from the Psychology Management System (PMS), where data is routinely collected 
from AMH speciality staff using the standard discharge form (see Appendix 1.1), which every 
referral received to the service is rated on for the purposes o f service audit. Data was exported into 
a statistical package for windows (SPSS v l 1.0) for examination. Patient identifiers were removed 
from the data set and each patient was allocated an identity number in order for the data to be 
anonymous. Referral agent identifiers were also removed. Missing data was identified through 
frequency reports and was recovered through case file searches.
Referrals were examined in terms o f referral characteristics and referral outcomes for the whole 
AMH speciality and were also examined between geographical areas and referral agents. Specific 
referral characteristics examined were patient characteristics (age and gender) and referring 
problem (primary problem, chronicity, severity and complexity). Referrals are rated by AMH 
speciality staff on standard discharge forms using either information gathered during assessment or 
subsequent sessions, or with the detailed information provided by the referring agent at time of 
referral if assessment sessions were not attended by, or offered to, patients. Umbrella categories of 
disorders/difficulties experienced by clients, as rated by AMH speciality staff members (using the 
same method detailed above), were also taken from individual discharge forms currently used 
within the department. Fifteen umbrella categories of disorders/difficulties are used encompassing 
over 80 diagnostic categories; Depressive mood, anxiety disorder, obsessive compulsive, 
personality problems, sexual problems, family/relationship problems, social functioning,
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adjustment difficulties with life events, eating disorder, sleep disorder, addiction, physical health 
problem, employment difficulties, intellectual impairment, and psychosis.
Discharge forms also provided the outcome o f each referral, completed by AMH speciality staff as 
standard, detailing session attendance, reason for discharge (planned discharge, re-referral, non- 
attendance etc), and subjective clinical judgment of outcome (e.g., improved, no change).
The data were examined for skewness and kurtosis. Data were not normally distributed therefore 
non-parametric statistics were employed. Data were examined using frequencies and cross 
tabulation. Mann Whitney-U tests were employed to test for significant differences between 
geographical area/referring agents and continuous variables, such as age or number o f sessions 
attended. Referral characteristics and outcomes were examined for significant differences between 
geographical area/referring agents using Chi-square tests, as data are regarded as nominal rather 
than ordinal/interval due to ratings being subjective and categorical, using probability levels 
calculated by the Bonferroni test on repeated post-hoc analyses (Brace et al., 2003).
Results
AMH Speciality: Referral Characteristics
A total number o f 1303 adult mental health cases were recorded as being referred between 1st 
October 2002 and 30th September 2003 and subsequently discharged by 6th May 2004. The mean 
age o f the sample was 37.14 (SD=11.71), with ages ranging from 17 to 64, and 65.5% (853) of the 
sample was female and 34.5% (450) was male.
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Referring Agents
There were three major referral agents to the AMH speciality, namely, General Practitioners (GP) 
(n=962, 73.8% of all referrals), Community Mental Health Teams (CMHT) (n= 124, 9.5%) and 
Psychiatric Medical Practitioners (PMP) (n=117, 9.0%). The twelve remaining referral agents 
consisted o f other mental health related professionals (n=100, 7.7%).
Problems Experienced
Approximately one quarter o f the total number of referrals received (n=1303) were assessed, by 
AMH speciality staff on discharge forms, as primarily experiencing an anxiety disorder (n=324, 
24.9%), one quarter a depressive disorder (n=320, 24.6%), 10.1% (n=132) with family or 
relationship difficulties and 8.5% (n= 111) with difficulty adjusting to life events (table 1). Of the 
total number o f referrals (n=1303) sent to the department a number o f referrals (n=164, 12.6%) did 
not have a specific primary diagnosis rating due to clients dropping out o f the speciality before a 
full assessment of presenting difficulties was completed or because o f limited referral information 
being provided by referral agents for clients that did not attend the AMH speciality prior to 
discharge (due to not attending or not being offered an appointment).
TABLE 1: Umbrella term of specific primary diagnosis
Frequency Percent
Depressive Mood 320 24.6
Anxiety Disorder 324 24.9
Obsessive Compulsive 10 0.8
Personality Problems 56 4.3
Sexual Problems 17 1.3
Family/Relationship Problems 132 10.1
Social Functioning 53 4.1
Adjustment to Life Event 111 8.5
Eating Disorder 12 0.9
Sleep Disorder 4 0.3
Addiction 16 1.2
Physical Health 40 3.1
Employment Difficulties 33 2.5
Intellectual Impairment 3 0.2
Psychosis 8 0.6
Information not provided by referring agent 164 12.6
Total 1303 100.0
Problem Severity
O f the total number o f referrals (n=1303), AMH speciality staff rated client problem severity as 
mild (n=216, 16.5%), moderate (n=557, 42.7%), or severe (n=282, 21.6%). Remaining referrals 
not rated (n=249, 19.1%) were due to non-attendance (first or subsequent appointments) or limited 
referral information being provided by the referring agent at time o f referral.
Problem Chronicity
O f the total number of referrals (n=1303), chronicity was found to be mainly over one year 
(n=653, 50.1%), between six or twelve months (n=283, 21.7%), or less than six months (n=100, 
7.7%). Chronicity was unable to be rated in 267 cases (20.5%) due to non-attendance (first or
9
subsequent appointments) or limited referral information being provided by the referring agent at 
time o f referral.
Problem Complexity
O f the total number o f referrals (n=1303) the complexity o f problem varied between; ‘high degree’ 
(n=128, 9.8%), ‘moderate’ (n=419, 32.2%), ‘low degree’ (n=290, 22.3%), and ‘not complex’ 
(n=230, 17.7%). Complexity was not rated in 236 cases (18.1%) due to non-attendance (first or 
subsequent appointments) or limited referral information being provided by the referring agent at 
time o f referral.
Referral Characteristics: Discrepancies in Reported Data
Particular frequencies and percentages of referrals reported above differ between subsections, for 
example, severity (19.1%; n=249), complexity (18.1%; n=236) and chronicity (20.5%; n=267). It 
would be expected that the number o f cases ‘not rated’ would be consistent across referral 
characteristic categories, however, it should be noted that these numbers do not solely represent 
clients that have been seen by AMH speciality staff and staff may have rated clients problem 
severity by using information provided by the referring agent prior to discharge. Thus, some 
referral letters may have more detailed information specifying the complexity o f the problem but 
not enough relating to the chronicity or severity o f the problem (and vice versa) preventing the 
AMH speciality staff member to rate a particular category. Therefore, enough information was 
obtained through assessment/subsequent sessions or enough information was provided by the 
referring agent for AMH speciality staff to rate problem severity in 1054 referrals (80.9%) problem 
complexity for 1067 referrals (81.9%) and problem chronicity in 1036 referrals (79.5%).
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T h e  n u m b e r  o f  refe rra ls  ‘not ra ted ' on a charac ter is t ic  shou ld  n o t  be d ed u ced  as n o n -a ttendance  to
a llocated  appo in tm en ts .  A l th o u g h  d isc rep an c ies  be tw een  da ta  can  be  ex p la in ed  in genera l te rm s it 
is unc lea r  w hich  re fe rra ls  w ere  not rated and w hy  e.g., w ere  they  t ransfe r red  to ano th e r  area  prior 
to be ing  seen?  T h is  h igh ligh ts  g ro ss  d iff icu lties  w ith  the ra ting  and  sco r in g  o f  d isch arg e  fo rm s and 
the  inconsis tency  o f  ra t ing  p rac tices  b e tw een  A M H  spec ia li ty  staff.
AMH Speciality: Referral Outcom es
Attendance
O f  the total n u m b e r  o f  refe rra ls  rece ived  (n = 1 3 0 3 ) ,  50 .8 %  (n = 6 6 2 )  a t tended  th ree  o r  m ore  sessions, 
15% (n=  195) a t tended  one , 14 .7%  (n = 1 9 2 )  a t tended  tw o, and 19 .5%  (n = 2 5 4 )  d id  not a ttend at all 
p rior  to d ischarge  (d iag ram  1).
Diagram 1. Number of sessions attended for all referrals received
attended 20 or more
atten 
attended (
attended 13-19 Those referred to 




Frequencies reported for the number o f sessions attended by referrals sent to the service, are 
inclusive of referrals that were assessed on receipt o f referral to be either appropriate or 
inappropriate to the area/speciality. Therefore, although 19.5% (n=254) o f referrals did not attend 
the speciality at all prior to discharge this percentage includes referrals that did not attend 
appointments allocated to them, referrals that were assessed on receipt as not appropriate, and 
referrals that ‘opted out’ o f the speciality.
Between one and two percent o f referrals were not offered a locally based appointment, whether at 
the department or within a GP practice or health centre, requiring clients to travel longer distances 
to attend appointments.
Reason fo r  Discharge
O f the total number o f referrals (n=1303) received, main reasons for discharge were found to be; 
failure to attend during treatment (n=360, 27.6%), treatment completed (n=247, 19.0%), and 
problems resolved (n=175, 13.4%). The proportion o f referrals recorded as ‘never seen’ (n=133, 
10.2%), as the given reason for discharge, is the proportion o f clients that did not attend any 
appointments that were allocated to them. Only 3.1% (n= 41) o f referrals ‘opted out’ for their first 
appointment whereby declining to be seen by a member o f the department when near the top o f the 
waiting list (Table 2). It is unclear how many sessions were attended by referrals prior to 
discharge in the various subcategories given, such as ‘transfers’ or ‘failed to attend’.
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TABLE 2. Reason for Discharge
Frequency Percent
Opted out 41 3.1
Died 2 .2
Failed to attend 360 27.6
Never seen 133 10.2
No further improvement possible 126 9.7
Parental/client request 90 6.9
Problems resolved 175 13.4
Transfer to another clinician 41 3.1
Transfer to another area 16 1.2
Transfer to another agency 36 2.8
Treatment complete 247 19.0
Unable to attend 23 1.8
Inappropriate referral 1 0.1
Clinician did not report 12 0.9
Total 1303 100.0
Subjective Rating o f  Referral Outcome
O f the total number o f referrals sent to the AMH speciality (n=1303) nearly one half of clients 
referred were rated by AMH speciality staff at discharge as ‘improved’ (n=620, 47.5%), 11.2% 
(n=146) ‘unchanged’, and 0.6% (n=7) as ‘deteriorated’. The remaining 530 referrals (40.7%) were 
not rated on a subjective outcome category by AMH speciality staff due to never being seen 
(n=225, 17.3%), failure to attend (n=89, 6.8%), only seen once (n=193, 14.8%) or ‘other’ (n=23,
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1.8%). When excluding referrals not allocated to an outcome category due to these reasons, 80.1% 
o f referrals that participated in therapy with AMH speciality staff were discharged and rated as 
having made either much, moderate, or slight improvement.
Referral Outcomes: Discrepancies in Reported Data
Frequencies and percentages o f reported outcomes reported also differ between subsections. For 
example, attendance frequencies showed that 254 (19.5%) referrals did not attend the speciality at 
all prior to discharge. However, ratings for the subjective outcome reported that 225 (17.3%) 
referrals were never seen whereas ‘reason for discharge’ reported that 133 (10.2%) referrals were 
never seen.
The discharge form does not utilise the full variation o f outcome categories required to be rated 
within the subjective outcome subsection, for example, referrals that were ‘unable to attend’ or 
‘transferred’ can only be rated as ‘never seen’, ‘failed to attend’, or ‘other’ within the ‘reason for 
discharge’ section. This creates significant difficulties to track the outcome for referrals (i.e., what 
proportion of referrals that were never seen were those transferred to another area, service, or 
clinician, died, opted out, or were unable to attend prior to discharge?). Therefore it is advised that 
only the frequencies for improvement or deterioration reported in the subjective outcome section 
should be utilised as the ‘failed to attend’, ‘never seen’, ‘only seen once’ and ‘other’ frequencies 
are indescribable o f referral populations.
The most accurate and reliable subsection to refer to when reporting non-attendance by referrals is 
‘reason for discharge’ as it has a full breakdown o f the available referral outcomes. The 
breakdown records referrals that were transferred out with the service, opted out etc. Therefore
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categories such as ‘never seen’ and ‘failed to attend’ can be reliably reported for referrals that did 
not attend the speciality prior to discharge due to non-attendance o f allocated appointments 
(n=133; 10.2%) and for referrals that failed to attend during treatment sessions (n=360; 27.6%). 
Therefore the number o f referrals that were discharged from the speciality due to not attending 
appointments that were allocated to them was 37.8% (n=493).
In conclusion, subsections detailing referral outcomes are rated independently o f each other on the 
discharge form and discrepancies between frequencies can be explained by overlapping sub­
categories on the discharge form, rating errors, or inconsistencies between AMH speciality staff 
ratings. This highlights a significant problem with the current format and rating of the discharge 
form.
Geographical Area: Referral Characteristics & Outcome
AE* received 493 referrals (37.8%); NU received 555 (42.6%); ST received 125 (9.6%); and WG 
received 130 (10.0%) during the one-year period. There were no significant differences found 
between geographical areas and the gender o f referral (x2=0.318, df=3, /?=0.957, two-tailed) using 
a Chi-square test. Using a series o f Mann-Whitney-U tests no significant differences were found 
between geographical areas and the age o f referrals (see Appendix 1.2, table 1). Compared to other 
areas, where GPs were the main referral agent (86.2%, 71.5%, 75.2%), WG received more 
referrals from CMHT (51.5%) than GPs (35.4%).
In WG there was a higher percentage o f referrals for depressive disorders (38.5%) compared to 
other areas (22.5%, 22.9%, 25.6%) and also for anxiety disorders (27% compared to 21.5%,
* AE=Annandale & Eskdale; N U  = Nithsdale & Upper Nithsdale; WG= Wigtownshire; ST= Stewartry
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23.:%, 24.8%). The majority o f referrals from areas out with the department attended their 
psyihology appointments in a local health centre or GP practice (Table 3) reducing the time 
reqiired to travel to an appointment at the department.
Tabe 3. Location o f Appointment per Geographical Area
Area Total
AE* NU ST WG
Psychology D ept Count 22 392 17 3 434
% within Area 4.5% 70.6% 13.6% 2.3% 33.3%
Hedth center/G P surgery Count 461 159 107 126 853
% within Area 93.5% 28.6% 85.6% 96.9% 65.5%
Hopital/D ay H ospital Count 9 4 - 1 14
% within Area 1.8% 0.7% - 0.8% 1.1%
Hone Visit Count 1 - 1 - 2
% within Area 0.2% - 0.8% - 0.2%
Total Count 493 555 125 130 1303
% within Area 100% 100% 100% 100% 100%
Usiig a series o f Mann Whitney-U tests attendance did not differ significantly between areas (see 
Appndix 1.3, tablel). However, ST had the lowest first session DNA rate (8%) compared to other 
ares, 18.5%, 20.7% and 21.3% (Diagram 2).
A:=Annandale & Eskdale; N U  = Nithsdale & Upper Nithsdale; W G= W igtownshire; ST= Stewartry
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Those attended 1 attended 2 attended 3- attended 6- attended 9- attended attended 
referred to session 5 8 12 13-19 20 or more
service but
not seen N um ber o f  sessions attended in g roupings
□  Annandale & 
Eskdale
□  N ithsdale
□  Stewartry
□  W igtown
U sing  C h i-sq u a re  tes ts  re la t io n sh ip s  w ere  found be tw een  g eo g rap h ica l  a rea  and A M H  speciality  
s ta f f  ra tings  o f  sever i ty  (x2= 2 1 .798, df=6 , p = < 0 .0 0 l ) ,  ch ro n ic i ty  (x2= 4 2 .2 6 6 ,  d f=6 , /?=0.000) and 
co m p lex i ty  (x2= 6 6 .3 5 8 ,  d f= 9 ,  /?=0 .000) o f  referrals .  Pos t-hoc  C h i-sq u a re  an a ly ses  w ere  em ployed  
to ascerta in  w h ich  g eo g rap h ica l  a reas  d iffe red  s ign if ican tly ,  us ing  the  B onfe rron i  procedure  to 
ca lcu la te  s ig n if ican ce  levels. S tatis tical d if fe rences  found b e tw een  g eo g rap h ica l  areas, in term s o f  
severity , ch ro n ic i ty  and co m p le x i ty ,  can be v iew ed  in tab le  4.
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Severity AE vs. ST *"=18.481, df=2,/?= 0.000
Chronicity NU vs. AE x"=27.479, df=2, p=  0.000
WG vs. AE *"=27.479, df=2, p= 0.000
ST vs. AE *"=27.479, d0=2, p=0.000
Complexity ST vs. AE *"=31.181, df=3,p= 0.000
ST vs. NU *"=26.200, df=3,/j= 0.000
ST vs. WG *"=42.666, df=3,/>= 0.000
NU vs. WG *"=26.200, df=3,p=  0.000
AE vs. WG *"=31.181, df=3, / j= 0.000
The statistical difference found between ST and AE, in terms o f severity of referral, highlighted 
that both areas rated approximately half o f their referrals as moderately severe however the 
majority of remaining referrals within ST are rated as being o f mild severity whereas in AE the 
remaining majority are rated as severe. Within ST the majority o f referrals were rated as being 
either mild (30.6%) or moderately severe (55.6%) whereas in AE the majority were rated as being 
either moderately severe (52.9%) or severe (31.0%). This suggests that AMH speciality staff 
working in ST rate the majority o f their referrals as less severe than AE.
In terms of chronicity, AE differed from other geographical areas where the majority of referrals 
from NU (69%), WG (77.4%), and ST (66.9%) were rated as having their difficulties for over one
* AE=Annandale & Eskdale; N U  = Nithsdale & Upper Nithsdale; W G= W igtownshire; S T - Stewartry
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year compared to only 50% of AE referrals. AE had a higher percentage o f referrals (37.0%) rated 
as having their difficulties for 6-12 months compared to the other three geographical areas 
(<22.8%).
Within ST* the majority o f referrals were rated as being not complex (41.1%) compared to the 
other geographical areas where a more evenly spread of complexity was found, except from WG 
where the majority o f referrals were rated as being of moderate complexity (62.4%).
Outcome as rated by AMH speciality staff on discharge, did not differ significantly between 
geographical areas (x =5.476, df=3, />=0.140) using a Chi-square test. In relation to reason for 
discharge, WG had the highest percentages for ‘failed to attend’ (33.8%), much improved (23.8%), 
parental/client request (13.1%), and the lowest percentage for ‘did not opt-in’ (1.5%). ST had the 
lowest number o f referrals being discharged as ‘unchanged’ (4.8%) compared to other areas (AE 
=13.3%; NU= 10.5%; WG= 13.1%). AE and ST had higher rates for discharging due to problems 
having ‘resolved’ (16.4%, 16.8%).
Referring Agent: Referral Characteristics & Outcome
Using a Chi-square test no significant differences were found between referring agents and the 
gender of referral (x2=3.201, df=2, p=0.202, two-tailed). Using a series o f Mann-Whitney-U tests 
no significant differences were found between referring agents and the age of referrals (see 
Appendix 1.2, table 2). CMHT and PMP* referrals were mainly for depressive disorders (41.9%; 
39.3%) whereas GP referrals varied to a greater degree with the highest percentage being for
* AE=Annandale & Eskdale; NU = Nithsdale & Upper Nithsdale; WG= Wigtownshire; ST= Stewartry
* PMP= Psychiatric Medical Practitioner; CMHT= Community Mental Health Team; GP= General 
Practitioners
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anx ie ty  re la ted  d iso rd e rs  (2 6 .9 % )  and fam ily /re la t ionsh ip  p ro b le m s  (11 .4 % ).  T here  w ere  no 
s ign if ican t  d if fe ren ces  in sess ion  a t tendance  b e tw een  the th ree  m ain  referral  ag en ts  (see A p p en d ix  
3, tab le  2), h o w e v e r  G P  re fe rra ls  had a h ig h e r  first session  D N A  rate (1 9 .6 % )  co m p a re d  to C M H T  
(1 6 .1 % ) and P M P  (1 4 .5 % ).  A p p ro x im a te ly  one  third o f  refe rra ls  f rom  each  referral agent, G P  
(31 .5% ), C M H T  (2 7 .4 % ) ,  and  P M P  (29 .1% ), a t tended  3-5 sess ions  p r io r  to d isch arg e  (D iag ram  3).
D IA G R A M  3. N u m b e r  o f  S ess io n s  A ttended  per  R eferr ing  A g en t
■  O th e r  Referrers
□  GP
□  C M H T
□  PM P
T h ere  w as  a re la t ionsh ip  found  be tw een  re fe rr ing  agen t  and A M H  spec ia l i ty  s ta f f  ra tings o f  
severity  (x2=35.981, d f=4 , /?=0.000), ch ron ic i ty  (x2= 2 8 .2 4 2 ,  d f=4 ,  /?=0.000), and com plex ity  
(x2=69.475, df=6 , p=0.000) o f  re ferrals  u s ing  C h i-sq u a re  tests. P o s t-h o c  C h i-sq u a re  ana lyses  w ere  







attended attendedattended attendedThose attended 








N u m b e r  o f  sess ions  a t tended  in g ro up ings
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calculate significance levels. Statistical differences found between referring agents, in terms o f 
severity, chronicity, and complexity, can be viewed in table 5.
TABLE 5. Referral Characteristics: significant differences between referring agents
Referral
Characteristic
Referral Agent* Statistical Difference
Severity GP vs. PMP *'=33.449, df=2, p=  0.000
Chronicity GP vs. CMHT *'=21.900, df=2,p=  0.000
GP vs. PMP *'=21.900, df=2, p= 0.000
Complexity GP vs. CMHT *'=48.108, df=3,p= 0.000
GP vs. PMP *'=48.108, df=3,p= 0.000
The majority o f referrals received by GPs were rated as being either mild or moderately severe 
(76.5%) whereas the majority o f PMP referrals were rated as being either moderately severe or 
severe (92.0%). No significant differences were found between CMHT referrals and GP referrals 
in terms of severity as rated by AMH speciality staff members.
In terms o f chronicity, GPs differed from other referring agents. The majority o f referrals from 
CMHTs (81.7%) and PMPs (72.8%) were rated as having their difficulties for over one year 
compared to only 57.8% of GP referrals. Additionally, GPs had a larger percentage of referrals 
(31.2%) being rated as having their difficulties for 6-12 months compared to CMHTs (13.5%) and 
PMPs (18.4%).
* PMP= Psychiatric M edical Practitioner; CMHT= Community Mental Health Team; GP= General Practitioners
21
The majority o f CMHT referrals were rated as being moderately complex (64.2%). Other referring 
agents were found to have a more even spread of complexity, although a higher percentage o f GP 
referrals were rated as not complex (25%) compared to CMHT referrals (8.5%) and PMP referrals 
(10.7%). Additionally, more PMP referrals were rated as having a high degree o f complexity 
(22.3%) compared to CMHT referrals (16.0%) and GP referrals (8.8%).
PMP and CMHT referrals did not differ significantly in terms o f severity, chronicity, or 
complexity. AMH speciality staff ratings o f GP referrals, in comparison to CMHT and PMP 
referrals, were less severe, less chronic, and were mostly rated as either ‘not complex’ or having a 
Tow degree’ o f complexity (45.3%).
Outcome, as rated by AMH speciality staff on discharge, did not differ significantly between 
referring agents (x2=8.511, df=2, /?=0.140) using a Chi-square test. However, PMP had a higher 
percentage o f referrals being discharged due to ‘no further improvement possible’ compared to 
CMHT and GP referrals. PMP had the lowest percentage of referrals being discharged as ‘much 
improved’ (10.3%) and a higher percentage o f referrals being rated as ‘unchanged’ (14.5%) 
compared to GPs (18.3%; 9.9%). CMHTs had the highest percentage o f referrals being discharged 
as ‘much improved’ (19.4%) and ‘unchanged’ (17.7%). Over one quarter o f referrals received 
from PMPs (26.5%; n=30) were only seen once for assessment prior to discharge.
Discussion
The reliability and validity o f AMH speciality staff ratings o f outcome are questionable due to 
being subjective and not calibrated. More importantly however, categories used to rate referral
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outcomes on the discharge form grossly overlap, creating difficulties in obtaining an accurate 
picture o f referral outcomes. For example, it is unclear why referrals were ‘never seen’ or ‘failed 
to attend’ and why outcome was not subjectively rated. Additionally, it appears that AMH 
speciality staff ratings are inconsistent when defining ‘failure to attend’ and ‘never seen’ inhibiting 
an accurate reflection o f referral outcomes.
Although significant concerns surrounding the reliability and validity of discharge forms has been 
raised some findings are interesting to note. A high proportion (37.8%) o f referrals were 
discharged from the AMH speciality due to non-attendance (taken from ‘reason for discharge’ 
ratings; ‘failure to attend’ and ‘never seen’). This percentage includes clients that did not attend 
the service at all (never seen; 10.2%) despite being assessed on receipt o f referral as an appropriate 
referral, together with clients who stopped attending the service during therapy (failure to attend; 
27.6%). The impact of travelling in a rural area on attendance rates was unlikely to be an issue as 
approximately 98% of referrals were offered local appointments; therefore locality cannot be 
posited as a factor contributing to non-attendance. Nevertheless, first session non-attendance rate 
(10.2%) in the Dumfries and Galloway AMH speciality was found to be lower in comparison to 
other psychological services (ll% -20% ) (Trepka, 1986; Startup, 1994; Murray & Hewitt, 1996). 
Additionally, clients that stopped attending the AMH speciality during therapy (27.6%) was found 
to be similar to other psychological services (25-30%) (Weighill et al., 1983; Madden & Hinks, 
1987; Fadrid & Alport, 1993; Hughes, 1995; Startup, 1995).
Reasons for referral were similar to those of other services (Forsythe & Gallacher, 2003; Telford et 
al., 1996). Referrals varied in their severity, chronicity, and complexity. A majority of referrals 
however were rated as either moderate or severe and having their difficulties for over one year.
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Despite the variety in referral characteristics, over 80% of referrals seen by AMH speciality staff 
were discharged as having improved to some extent.
Comparison between Geographical Areas
Age, sex, and attendance rate did not differ between geographical areas. Statistical differences 
were found between areas in terms of severity, chronicity and complexity o f problem. 
Wigtownshire received more referrals from CMHT than GPs, compared to other areas, which may 
be a reflection of their GP referral pattern alone. Nevertheless, this difference may be responsible 
for the significantly higher percentage o f more chronic and complex referrals that Wigtownshire 
received compared to other areas. Additionally, the higher percentage o f depressive and anxiety 
related referrals in this area could be a result of the CMHT referring cases where medicated 
management is not appropriate for whole problem management, thus utilising psychological 
intervention for more complex cases.
The statistical differences found between Annandale & Eskdale and other areas in terms of referral 
chronicity could be a result of unreliable ratings, differing waiting times between areas or GP 
referral patterns. GPs within Annandale & Eskdale may be more receptive in detecting 
psychological difficulties earlier than GPs in other areas or have a more favourable attitude to 
psychological interventions and are thus more amenable to refer to psychological services.
Statistically Stewarty was found to differ significantly from all other areas in terms of referral 
complexity. The majority of referrals were rated as less complex, compared to other areas. 
Reasons for this difference are not explicit, as the chronicity o f Stewarty referrals were similar to 
other areas, and severity ratings lower than Annandale & Eskdale. Although statistically
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significant, differences may not be clinically significant and highlights reliability issues of 
subjective ratings o f referral characteristics between areas i.e., it is unclear whether one AMH 
speciality staff member’s subjective rating of low severity is the same as another’s.
In conclusion, each area team o f the AMH speciality provides psychological care to clients with 
difficulties with varying levels o f severity, chronicity and complexity. Although statistically it 
appears that some areas differ in terms of their referral characteristic populations, this may be an 
artefact o f AMH speciality staff ratings differing rather than the referral populations.
Comparison between Referral Agents
Age, sex, attendance, and outcome did not differ between referral agents. Statistical differences 
were found between referral agents in terms of severity, chronicity and complexity o f problem. 
The majority of GP referrals were rated as less severe than PMP referrals, less chronic than CMHT 
and PMP referrals, and were found to have a higher percentage of low complexity referrals than 
PMP or CMHT referrals. This could be a reflection of primary versus secondary service referrals 
where CMHT and PMP referrals would be expected to be more severe, complex and chronic due 
to clients having existing contact with mental health services. Nevertheless, statistical differences 
do not necessarily reflect a clinical difference in client populations referred by differing referring 
agents to the AMH speciality, as reliability issues regarding ratings o f referral characteristics must 
also be taken into account during interpretation. It is interesting to note that PMP and CMHT 
referrals did not differ in referral characteristics but did in referral outcome (although not 
significantly) where CMHT referrals had a higher percentage o f referrals being discharged with 
improvement and over a quarter of PMP referrals were discharged after one assessment session.
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This may reflect a need to revise guidelines o f referral suitability and highlight a training need of 
Psychiatric Medical Practitioners regarding referral suitability to the AMH speciality.
The higher percentage o f referrals from CMHT discharged as ‘unchanged’ and PMP referrals 
being discharged after one assessment session may reflect the severity, chronicity and complexity 
of problems that represent cases not amenable to psychological intervention. It may also be the 
case that CMHTs are more familiar with the clients they refer, o f psychological intervention, and 
the treat-ability of problems, resulting in better treatment outcomes. However, the large 
percentage o f referrals found to be discharged as ‘unchanged’ and ‘deteriorated’ from CMHTs and 
PMPs may also represent a proportion o f ‘last chance’ referrals to psychological services where 
secondary services have not been able to make an impact on the referral’s presenting problem 
therefore psychology seems the other alternative.
In conclusion, clients referred by the three main referring agents have been rated to have 
difficulties with varying levels o f severity, chronicity and complexity. For example, GPs have been 
rated by AMH speciality staff to refer less severe, chronic and complex referrals than secondary 
mental health service providers i.e., CMHTs and PMPs. Although this difference may be 
understandable, in terms o f referral characteristics, this may also be an artefact o f AMH speciality 
staff ratings differing rather than the referral agent’s client population.
Recommendations for Service Provision and Future research
■ The current discharge form employed by the speciality should be extensively reviewed and 
adapted to address some of the inconsistencies highlighted earlier in this report. Specifically
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the discharge form needs to incorporate the variability of ‘outcomes’ available to referrals. For 
example, the subjective outcome section should include the additional ‘reason for discharge’ 
categories such as ‘transfer to another clinician’. This would minimise the confusion 
surrounding discrepancies between frequencies reported for ‘never seen’ and ‘failure to attend’ 
between outcome categories. Categories such as ‘never seen’ and ‘failure to attend’ should be 
broken down into more definable categories such as ‘never seen -  did not attend allocated 
appointment’ or ‘failed to attend -  after 1/2/3/4 sessions’.
■ Outcome categories rated by AMH speciality staff are presently subjective and should have 
defining criteria to ensure consistency across geographical area/AMH speciality staff member. 
This should limit future results being unclear due to subjective measures. Additionally, 
research investigating the inter-rater reliability and intra-rater reliability of AMH speciality staff 
ratings o f referral characteristics may also be useful following adaptations to the discharge 
form.
■ Staff training demonstrating how to rate referrals and explanation o f categories available for 
rating should be incorporated into speciality workshops or inductions to ensure consistency of 
rating.
Dissemination of Findings
The findings presented in this audit will be presented to the Director of Psychological Services, 
speciality staff, and management staff o f the Department of Psychological Services and Research 
in August 2004. This report will also be sent to the department o f Clinical Effectiveness in 
Dumfries and Galloway for general staff access.
The Director o f Psychological Services may present select results to Senior Management Members 
of the Dumfries and Galloway NHS Health Board.
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Abstract
There is concern that older patients may be at risk o f ‘Postoperative Cognitive Dysfunction’ (POCD) 
arising from surgical procedures. The purpose o f this review was to systematically review the quality 
of the evidence for such impairment following general anaesthesia, as clinicians should be aware of 
the incidence, risk, and features associated with POCD. The search strategy involved a computerised 
search o f all major health care databases using key terms to identify papers suitable for review. A 
total o f eight papers were retained for review. Criteria assessing methodological quality was tailored 
to the investigation o f  POCD using ‘Statement o f Consensus’ and ‘SIGN’ guidelines. Whilst a 
number o f reported incidences appear reliable, risk factors and features contributing to POCD 
remain unclear due to methodological limitations of the current literature. High quality studies 
found POCD to occur postoperatively in 14.3% - 28.5% o f older adults at approximately one week, 
8.1% - 20.4% of older adults at three months, and to persist in <1% at 1-2 years following surgery. 
Risk factors identified with POCD at one week were increasing age, hospitalisation, little education, 
and postoperative complications and infections. Risk factors associated with cognitive decline at 
three months were increasing age and benzodiazepines before surgery being protective. Risk factors 
associated with POCD at 1-2 years were increasing age, POCD at one week, and infection within the 
first three postoperative months. Limitations o f the current literature are discussed and suggestions 
for future research are proposed.




The Scottish Executive has estimated that between the year 2000 and 2031 the number of people 
over the age o f 65 is expected to increase from 787,000 to 1,200,000 and those over 85 years from 
84,000 to 150,000 [Scottish Executive, 2002]. Such ongoing changes in the demographic 
characteristic will represent a general increase in the proportion o f older adults leading to an 
assumed growth in the numbers presenting to hospital for surgery. Changes o f this nature are 
already being evidenced within healthcare settings. For example, the number o f older adults 
receiving hip replacement surgery has doubled in the period from 1978 to 2002 [Scottish Executive, 
2002]. The reasons for increased life expectancy o f older adults are complex and likely include 
cultural and societal changes as well as improvements in healthcare, medical, and surgical 
interventions. Whilst modern anaesthetic techniques and surgical methods have improved survival 
rates, there is however concern that older patients may be more vulnerable to cognitive impairment 
arising from surgical procedures. The purpose of this review is to determine the quality o f the 
evidence for such impairment.
POCD
Cognitive decline following surgical procedures is known as ‘Postoperative Cognitive Dysfunction’ 
(POCD) which is a term used to convey a mild neurocognitive disorder [Bekker & Weeks, 2003]. 
Although not referenced in the American Diagnostic and Statistic Manual o f Mental Disorders, 
Fourth Edition-TR, it is considered to be a cognitive disorder not otherwise specified, characterised 
by impairment o f memory, concentration, executive functioning, disturbance in attention or speed o f 
information processing, perceptual-motor abilities, or language comprehension [Moller, 1997]. It is 
distinct from delirium and other confusional states that may occur in response to medical treatment 
and can be differentiated from the acute effects of medication in the immediate postoperative period
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[Silbert et al. 2001]. It presents as less severe than dementia and has been reported to have 
socioeconomic implications encompassing a loss of independence, need for extra nursing care, and a 
high discharge rate to long-term care [Bekker & Weeks, 2003]. Several authors have also proposed 
a relationship between postoperative cognitive dysfunction and subsequent dementia [Newman et al. 
1995; Ritchie et al. 1997; Roman et al. 2002; Pfitzenmeyer et al. 2001]. The potential negative and 
significant outcomes arising from surgery has therefore been of great interest to researchers and 
clinicians alike, and has even prompted the development of an ‘International Study of Postoperative 
Cognitive Dysfunction’ (ISPOCD) group, to examine POCD further.
Early Research on POCD
Numerous iatrogenic variables have been proposed as potentially contributing to the development of 
POCD including factors within the preoperative [Chung et al. 1989; Crul et al. 1992; Berggren et al. 
1987], intra-operative [Chung et al. 1987; Flatt et al. 1984; Hole et al. 1980; Dodds & Allison, 1998] 
and postoperative period [Smith et al. 1991, Berggren et al. 1987, Katz & Fagraeus, 1990, Edwards 
et al. 1981, Rosenberg & Kehlet, 1993]. A review of earlier research stated that exposure to general 
anaesthesia can be a cause o f short-term and long-term cognitive impairment and was a common 
complication in elderly patients undergoing cardiac and non-cardiac surgery [Dodds & Allison, 
1998], but concluded that causes were difficult to establish. However, numerous methodological 
limitations have been shown in earlier studies o f POCD [Rasmussen, et al. 2001; Dijkstra & Jolles, 
2002] which have compromised the generalisability of the findings.
Methodological Limitations
Dijkstra & Jolles [2002] noted such methodological limitations as being the selection of 
inappropriate neuropsychological assessments, unresolved practice effects, variable definition of 
cognitive decline, and ecological validity o f assessments. The selection bias o f patients pertains to
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the exclusion o f those with pre-existing cognitive deficits so few studies are representative of an 
older adult population. It has also been highlighted that anxious, depressed, or fatigued patients are 
more likely to refuse participation, which may result in vulnerable populations who might be more 
susceptible to cognitive decline being excluded from analyses, thus reducing the apparent incidence 
of POCD in older adult populations.
Methods to define cognitive decline in earlier research typically compare mean group performances. 
This has been suggested to artificially reduce the apparent incidence o f POCD in older adults, 
particularly when examining middle-aged and older adults together. Comparing means o f test 
performance neglects intra-individual changes and better performances by middle-aged adults 
underestimate deteriorations in older populations by averaging effects. Consequently various 
statistical methods to assess intra-individual changes have been used to determine whether POCD 
has occurred. Methods include the ‘20% decline on 20% of the tasks’, ‘one standard deviation 
decline on two or more tasks’, or the ISPOCD group’s modified reliable change index (I-RCI), 
which have been discussed and examined in more depth by Lewis et al. (2006). Following their 
examination of the three statistical methods they conculded that using the modified reliable change 
index is preferred as it demonstrates the greatest combination o f sensitivity and specificity in 
comparison to the other methods.
Statements o f consensus were published [Murkin et al. 1995; Murkin et al. 1997] to guide 
researchers in choosing optimal assessments, reduce potential confounding factors to 
neuropsychological test performance, and appropriate analyses. Subsequent publications by the 
ISPOCD group [Rasmussen et al. 2001] have added to these recommendations. These include using 
the ISPOCD neuropsychological test battery, enrolment of a normative control group to control for 
practice effects and random variation, and analyses examining intra-individual changes [Rasmussen
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et al. 2001]. The test battery assesses a balanced number o f cognitive domains comprising o f four 
standardised and sensitive neuropsychological measures: the Visual Verbal Learning Test [Brand & 
Jolles, 1985], assessing delayed recall & retrieval; memory; the Concept shifting test [Reitan, 1958], 
assessing executive functioning and speed o f processing; the Stroop colour word inference test 
[Bohnen et al. 1992], assessing selective attention, mental speed, and interference susceptibility; and 
the letter-digit coding test [Lezak, 1995], assessing processing & psychomotor speed. Seven 
parameters from the four tests are used to compare intra-individual changes between assessment 
sessions.
To date there has not been a systematic review of literature examining POCD in a non-cardiac 
surgical population using general anaesthesia. Given the risk for cognitive decline following 
surgery, the projected increase o f older adults likely to attend and survive non-cardiac surgery, and 
the known vulnerability o f older adults to cognitive dysfunction, it is important that clinicians are 
aware o f POCD in the older adult population. This is particularly important when examining older 
adults presenting with cognitive complaints given the likelihood they may have had a recent surgical 
procedure. Therefore, our aim is to systematically review the incidence of, risk factors contributing 




This systematic review aimed to address the question: In the older adult non-cardiac surgical 
population undergoing general anaesthesia:
• What is the incidence o f POCD?
• What risk factors contribute to POCD?
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• What are the features o f POCD?
Search Strategy
A number o f sources were used to identify studies for possible inclusion in this review. These 
included a search across the following electronic bibliographic databases:






The electronic search used eight key terms to reflect the main components o f the systematic review 
question. The following terms were used in the search of the electronic databases








9. 1-2 combined using OR
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10. 3-5 combined using OR
11. 6-8 combined using OR
12. 10-11 combined using AND
13. 9 & 12 combined using OR
Duplicates were removed and searches limited to English Language and publication year 1993-2006. 
Citation lists o f retrieved studies were examined and hand searches o f key journals, British Journal 
of Anaesthesia, Acta Anaesthesiologica Scandinavica, and Anaesthesia, were carried out to identify 
further articles. Reference lists were also reviewed from retrieved articles.
Inclusion Criteria
■ Non-cardiac or non-neurological surgery using general anaesthetic.
■ Participants aged >60 years.
■ Standardised and reliable neuropsychological assessments used to assess cognitive
functioning (not just cognitive screen).
■ Studies assessing intra-individual preoperative and postoperative cognitive change.
■ A normal control group recruited to control for practice effects on neuropsychological tests, 
normal ageing, and test variation.
■ Sensitive method o f statistical analysis used to ascertain cognitive decline.
■ Measures o f cognitive performance detailed as outcome measures.
■ Peer reviewed journal article.
37
Results
Outcome o f  Search Process
The computerised search yielded 507 papers. Only 26 were retained as being relevant to the research 
question on the basis o f their titles and abstracts. O f the 26 articles 18 did not meet inclusion criteria 
(see Appendix 2.2). No further papers were identified from searching the reference lists o f papers 
included from the electronic search or from hand searches of key journals. A total of eight studies 
were reviewed.
Characteristics o f  Excluded Papers
Studies were excluded if they did not report separate incidences o f POCD for older age groups. 
Therefore a total o f 5 studies were excluded [Abildstrom et al. 2004; Ancelin et al. 2001; Grichnik et 
al. 1999; Linstedt et al. 2002; Moller et al. 1993]. Three studies were excluded due to using 
insensitive cognitive screening tools such as the MMSE [Chen et al. 2001; Milisen et al. 1998; 
Papaioannou, 2005]. Five were excluded because cognitive functioning was not formally assessed 
preoperatively [Bennett et al. 2004; Gruber-Baldini et al. 2003], postoperatively [Kaneko et al.
1997], or not at all [Rodig et al. 1999; Ward et al. 2005], Two were excluded for not assessing acute 
postoperative functioning when assessing late outcome [Hall et al. 2005; Tamura et al. 2004]. Two 
studies were excluded for failing to recruit a normal control group or to control for learning or 
practice effects [Campbell et al. 1993; Williams-Russo et al. 1995]. One meta-analysis was excluded 
because it combined POCD incidences from general, regional, and local anaesthesic populations 
[Rasmussen, Siersma, and the ISPOCD group, 2004].
Assessment o f  Methodological Quality
The methodological quality o f RCT and cohort studies was assessed using checklists adapted from 
the Scottish Intercollegiate Guidelines Network (SIGN) ‘Guideline Developers Handbook’ [Scottish
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Intercollegiate Guidelines Network, 2004]. Criteria devised for assessing methodological quality 
also included factors recommended by the ‘Statement o f Consensus’ and ISPOCD group [Murkin et 
al. 1995; Murkin et al. 1997; Rasmussen et al. 2001]. The checklists include criteria assessing the 
research aims, population, design, neuropsychological assessment battery used, confounding factors, 
and statistical analyses (see appendix 2.3).
All studies were scored on 44 factors of methodological quality. The reviewer was not blind to the 
author, institutions, journal o f publication, or results. Possible scores ranged from 0 to 54, as higher 
weightings were given to important methodological items such as recruitment of an adequate control 
group, and were transferred into quality categories representing the overall percentage of quality 
criteria met:
A = > 75% (high quality -  all or most criteria have been fulfilled)
B = 60-74% (moderate quality -  an adequate number of the criteria have been fulfilled)
C = 50-59% (low quality -  some of the criteria have been fulfilled)
D = < 49% (poor quality -  very few of the criteria have been fulfilled).
No meta-analytic techniques were conducted in the present review given the heterogeneity of 
anaesthetic agents, time o f preoperative and postoperative assessments, and surgical procedures 
used, in addition to certain methodological limitations of studies. Indeed, the methodological 
limitations highlighted within a recent systematic literature review of POCD in cardiac populations 
indicated that a discursive review would be more appropriate [Van Dijk et al. 2000].
Data Extraction
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Data were extracted from each o f the included studies. The data reflected the variables identified in 
the inclusion criteria and the aim of the review. A summary of the data extracted for each study is 
presented in Table 1.
[Insert Table 1. here]
O f the 8 studies reviewed,
4 met criteria for an A quality rating: Abildstrom et al. 2000
Canet et al. 2003 
M olleretal. 1998 
Rasmussen et al. 2003 
4 met criteria for a B quality rating: Dijkstra et al. 1999
Rasmussen et al. 1999 
Rentowl & Hanning, 2004 
Rohan et al. 2005
No studies met criteria for a C or D quality rating, therefore the quality o f papers’ examined in the 
review are considered to be o f moderate to high quality.
Reliability o f  Quality Rating
An independent examiner rated all studies included in this review and the index o f agreement was 
87% according to the category ratings (Cohen’s Kappa co-efficient statistic= 0.874; excellent inter­
rater agreement). Disagreement on one category was a result o f a one-point difference causing a 
crossing o f the category threshold of quality from B to A. The author and independent examiner met
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to review disagreement on one factor o f methodological assessment and agreed on score weighting 
following a short discussion.
Review o f  Findings
Studies will be reviewed in order o f quality rating allocated within the subheadings: Incidence; Risk; 
Features.
Incidence
The reported incidences o f POCD are shown in table 2.
[Insert Table 2. here]
20-24 Hours Postoperatively
O f eight studies included in this review only one investigated the incidence o f POCD 20-24 hours 
postoperatively [Rohan et al. 2005; moderate quality] using a randomised design comparing two 
anaesthetic agents. The sample size o f 30 and an age-matched control group (n=15) was supported 
by a power calculation. The ISPOCD RCI method was used to determine POCD [Moller et al.
1998], which has been shown to be reliable and sensitive [Lewis et al. 2006; Keizer et al. 2005]. 
Incidence o f POCD at 20-24 hours following surgery was 47% (95% Cl 21-72%) and was 
significantly greater than the incidence o f 7% (95% Cl 6-19%) within the control group (p= 0.03). 
Nevertheless, the external validity was reduced as the sample is not considered to be entirely 
representative o f the older adult population as exclusion criteria included pre-existing cognitive 
dysfunction. The method used to assess cognitive dysfunction further reduced validity as only two 
components o f the ISPOCD test battery were administered thus cognitive domains examined were 
unbalanced. In addition, factors known to contribute to test performance variability were not
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controlled for (e.g., testing environment, postoperative pain, acute testing of cognitive functioning 
20-24 hours following anaesthetic agent). Therefore the incidence o f cognitive dysfunction 20- 
24hours postoperatively is likely to be overestimated.
One week postoperatively
Six out of eight papers investigated the incidence of POCD at one week, or on day of discharge, 
following surgery [Moller et al. 1998 [high quality]’, Canet et al. 2003 [high quality]; Rasmussen et 
al. 2003 [high quality]’, Dijkstra et al. 1999 [moderate quality]’, Rasmussen et al. 1999 [moderate 
quality]’, and Rentowl & Hanning, 2004 [moderate quality].
M oller et al. [1998; high quality] examined POCD in 947 elderly patients aged 60-79 undergoing 
major surgery via a multi-centre prospective cohort design. A healthy non-surgical control group 
was recruited by newspaper advertisement using the same criteria as patients (n=176) to control for 
practice effects using the ISPOCD test battery. The sensitive I-RCI method to determine and define 
POCD was used. Moller et al. (1998) found that one week following surgery, or on day o f discharge, 
the incidence of patients found to have POCD using general anaesthesia was 25.8% (95% Cl 23.1- 
28.5) and was significantly greater than 3.4% (95% Cl 1.3-7.3) within the control group (/?<0.0001). 
Nevertheless, external validity was reduced due to sample bias (background data for refusals not 
being available i.e., refusal may be specific to vulnerable or at risk patients and exclusion criteria 
included pre-existing cognitive dysfunction) and not controlling for confounding variables that may 
have contributed to random variation (reduced environmental consistency between testing sessions 
and assessing patients one day preoperatively when anxiety is increased).
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Rasmussen et al. [2003, high quality] investigated the effects o f general anaesthesia (n=217) in 
comparison to regional anaesthesia (n=221) in a randomised controlled clinical trial using the 
sensitive ISPOCD method to determine and define POCD. Data to control for practice effects were 
those obtained during the Moller et al. (1998) study. Using an intention to treat analysis, one week 
following surgery the incidence of patients found to have POCD undergoing major surgery using 
general anaesthetic was 19.7% (95% Cl 14.3-26.1) and was significantly greater than the incidence 
of 3.4% (95% Cl 1.3-7.3) in controls. When using a per protocol analysis the incidence of POCD at 
one week was found to be 21.2% (95% Cl 15.0-28.4) and was also significantly greater than the 
incidence found within controls. Nevertheless the external validity o f the study is reduced due to a 
number o f factors such as no prospective power calculation determining sample size and sample bias 
(as level o f education was not controlled for, a factor known to be more vulnerable to POCD and 
exclusion criteria included pre-existing cognitive dysfunction). In addition, confounding variables 
known to affect performance (reduced environmental consistency between testing sessions and 
assessing patients one day preoperatively) were not adequately controlled.
Canet et al. [2003; high quality] investigated POCD in 372 patients undergoing various minor 
surgical procedures using general anaesthetic in a multi-centre prospective between groups cohort 
design. Patients were allocated to inpatient or outpatient care according to local practice rather than 
randomisation. The ISPOCD test battery was administered and the I-RCI methods to determine and 
define POCD using control data from Moller et al. (1998) were employed. At approximately one 
week postoperatively the incidence o f patients found to have POCD undergoing minor surgery using 
general anaesthesia was 6.8% (95% Cl 4.3-10.1), not significantly differing to the incidence of 3.4% 
(95% Cl 1.3-7.3) found in controls. The higher incidence found in patients therefore may be a result 
of random variation. Cognitive dysfunction however significantly differed between inpatients and 
outpatients at one week (9.8% [95% Cl 5.7-15.4] vs. 3.5% [95% Cl 1.4-8.0]; /?=0.033). However on
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inspection o f confidence intervals it is evident that control group values capture values for patients 
indicating ‘no effect’. The external validity of the study is further reduced as it was not supported by 
a power calculation (therefore vulnerable to Type II error), demonstrated sampling bias (exclusion 
criteria included pre-existing cognitive dysfunction), and did not control for confounding variables 
that may contribute to random variation (reduced environmental consistency between testing 
sessions and assessing patients one day preoperatively).
Dijkstra et al. [1999; moderate quality] investigated POCD and cognitive complaints in 56 older 
patients following major non-cardiac surgery using a prospective cohort design. The ISPOCD test 
battery was administered to patients, and the I-RCI method was applied to determine and define 
POCD. Controls were recruited via newspaper advertisement using the same inclusion criteria for 
patients (n=50). One week following surgery the incidence of POCD was 27% (Cl not stated), and 
was significantly greater than 6% (Cl not stated) found in recruited controls (p=0.048). As 
confidence intervals are not provided range of effect sizes cannot be examined when interpreting 
differences between patients and controls. This is a major limitation as it is the effect size that 
determines the importance o f findings, not the presence o f statistical significance. Also, the sample 
size was not supported by a power calculation. The external validity o f the study was significantly 
reduced as the control group is not considered to be a suitable comparison for patients as they were 
significantly younger and more educated than patients. Even after adjustment for these variables 
patients still performed significantly worse on 3 test variables preoperatively, therefore methods 
employed to control for learning effects may not be reliable. Sampling bias (exclusion criteria 
included pre-existing cognitive dysfunction) and not controlling for confounding variables (reduced 
environmental consistency between testing sessions and assessing patients one day preoperatively) 
further reduce external validity.
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Rasm ussen et al. [1999; moderate quality] examined diazepam and its relationship with POCD, one 
week postoperatively, or on day o f discharge, in elderly patients. The sample was a subgroup of 
patients (n=35) within the Moller et al. (1998) study, therefore methods to identify and determine 
POCD were that o f the ISPOCD group. One week following surgery the incidence o f POCD in 
patients was 48.6% (95% Cl 31.4-66.0), which was significantly greater than the 3.4% (95% Cl 1.3- 
7.3) found in controls. However the external validity and methods to reduce bias within the study is 
significantly reduced as five patients had postoperative complications and confounding factors 
known to affect test performance were not controlled for in analyses (mood and postoperative 
benzodiazepine prescription less than 24 hour before the postoperative neuropsychological test). 
Therefore changes in test performance are significantly vulnerable to confounding factors and 
incidences are considered unreliable.
Rentowl & H anning  [2004; moderate quality] recruited 53 patients undergoing major surgery to 
pilot whether odour identification deficit could be a marker for POCD using a prospective cohort 
design. The ISPOCD test battery and I-RCI methods to determine and define POCD were 
employed using control data from Moller et al. (1998). Complete data were available for only 34 
patients. At the first postoperative test session (7-15 days postoperatively) the incidence of POCD 
was 8.1% (95% Cl 0.0-16.9) and did not differ significantly from controls (3.4%, 95% Cl 1.3-7.3). 
Confidence intervals for effect sizes are wide indicating low power to detect an effect (vulnerable to 
Type II error), which is likely to have resulted from the sample size not being supported by a 
prospective power calculation. The external validity and methods to reduce bias within the study is 
also inadequate due to sampling basis (background data was not examined for patients who dropped 
out during the study therefore withdrawal may be specific to vulnerable or at risk patients) and not
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controlling for confounding variables that may have contributed to random variation (reduced 
environmental consistency between testing sessions and assessing patients one day preoperatively).
The reliability o f some incidences approximately one week postoperatively are questionable due to 
failure to control important confounding factors [Rasmussen et al. 1999], reporting non-significant 
results [Canet et al. 2003; Rentowl & Hanning, 2004] and failure to report effect sizes [Dijkstra, et 
al. 1999]. It can be reported however that the incidence o f POCD approximately one week 
following major surgery in cognitively intact older adults ranges from 14.3% to 28.5%, at the 95% 
confidence interval [Moller et al. 1998 & Rasmussen et al. 2003; high quality].
Three months postoperatively
A number o f studies did not find a significant difference between neuropsychological test 
performance in patients and controls three months postoperatively [Dijkstra et al. 1999; Canet et al. 
2003; Rentowl & Hanning, 2004]. Confidence intervals reported for studies captured values 
reflecting no effect at the 95% confidence interval. Accordingly, these studies lacked statistical 
power and non-significant results may be an artifact of Type II error.
M oller et al. [1998] found the incidence o f cognitive dysfunction at three months postoperatively to 
be 9.9% (95% Cl 8.1-12.0) and was significantly greater than the incidence o f 2.8% (95% Cl 0.9- 
6.6) found in controls (p=0.0037). However, minor reduction o f external validity is apparent due to 
having a partially unrepresentative sample and not controlling for some confounding factors.
Using an intention to treat analysis Rasm ussen et al. [2003] found the incidence o f cognitive 
dysfunction in patients to be 14.3% (95% Cl 9.5-20.4), significantly greater than the incidence of 
2.8% (95% Cl 0.9-6.6) within controls at three months. When using a per protocol analysis the
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incidence was also significantly greater than controls 13.1% (95% Cl 8.1-19.7). External validity of 
results are reduced however due to lack o f statistical power and sample bias.
No study reported whether POCD at three months was persisting from one week with exception 
from Rentowl & Hanning (2004) who found no patient with POCD at both test sessions. Patients 
defined as having POCD at three months therefore may have cognitive decline for other reasons if 
dysfunction was not identified postoperatively at one week. Therefore it is questionable if cognitive 
decline at three months can reliably be classified as POCD.
1-2 years postoperatively
One study examined POCD after a significant period following surgery. Abildstrom  et al. [2000; 
high quality] investigated the persistence o f POCD at 1-2 years by following-up 336 patients from 
the Moller et al. (1998) cohort. Patients were administered the ISPOCD test battery and POCD was 
determined using the I-RCI method. Control data were obtained from 47 o f the original controls. At 
1-2 years, 10.4% (95% Cl 7.2-13.7) o f patients were found to have cognitive dysfunction, a similar 
incidence to that found in controls (10.6%, 95% Cl 1.7-19.4). This suggests that observed cognitive 
decline may have occurred due to normal ageing. However, o f patients who had completed all 
testing sessions, only 3 (0.9%) had POCD at all sessions. The likelihood o f this occurring is 1:64 000 
(0.002%). This incidence however may be grossly underestimated due to initial sampling bias, 
inadequate control group size and inconsistent test administration (different examiner and inter-rater 
agreement not reported).
Risk Factors for Development o f POCD
Risk factors found to be associated with the development of POCD are shown in table 3.
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[Insert Table 3. here]
Moller et al. [1998; high quality] used a multiple logistic regression to investigate associations 
between potential risk factors and the development of POCD. A significant relationship between 
early POCD (at one week) and increasing age (odds ratio OR 1.3 [95% Cl 1.0-1.7], p=0.03), 
increasing duration o f anaesthesia - difference o f 1 hour (OR 1.1 [95% Cl 1.0-1.3] /?=0.01), little 
education (OR 0.6 [95% Cl 0.4-0.9], p=0.002), second operation (OR 2.7 [95% Cl 1.1-6.6], p=0.03), 
postoperative infection (OR 1.7 [95% Cl 1.0-2.8], p=0.04), respiratory conditions (OR 1.6 [95% Cl 
1.0-2.6], p=0.05) and centre (p=0.0001) was found. The authors report that effect of centre in the 
risk-factor analysis for early POCD may reflect differences in procedures, anaesthetic agents, and 
population characteristics, but cannot be explained by the analysis. Significant associations were 
found between POCD at three months and age (OR 2.1 [95% Cl 1.4-2.9], /?<0.0001) and 
benzodiazepines before surgery (i.e., protective) (OR 0.4 [95% Cl 0.2-1.0],p=0.03).
Despite finding no significant differences between patients and controls, Canet et al. [2003; high 
quality] used multiple logistic regression analysis to examine risk factors for POCD. They found 
associations with age greater than 70 (OR 3.8 [95% Cl 1.45-10.1], /?=0.01) and inpatient surgery 
(compared to outpatient; OR 2.8 [95% Cl 1.05-7.4], p=0.04) for POCD at one week. The validity of 
relationships is questionable however given the absence o f POCD being reliably identified within 
the patient group initially due to Type II error.
Dijkstra et al. [1999; moderate quality] investigated potential risk factors contributing to intra­
individual changes using a stepwise hierarchical multiple regression model. Factors included in the 
analysis did not contribute significantly to the total explained variance in dependant variables (short
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and long term intra-individual changes). However this may be a result of having an inadequate 
control group or reduced power for statistical analysis resulting in Type II error.
Rasm ussen et al. [1999; moderate quality] found that blood concentrations o f diazepam and 
desmethyldiazepam in patients with and without POCD did not differ significantly (Mann-Whitney 
test, /?>0.4). In a multiple linear regression analysis only age was found to predict intra-individual 
change at one week. The analysis was repeated excluding patients who had received zopiclone 24 
hour before testing however no further predictors were identified.
Rentowl & H anning [2004; moderate quality] used binary logistic regression analysis to investigate 
associations between POCD and potential risk factors. No associations between odour identification, 
age, smoking, alcohol intake, gender or MMSE score and POCD at one week or three months were 
found. This may also be an artifact o f Type II error and not entering, or controlling for, factors 
known to contribute to the development o f POCD [Moller et al. 1998].
A bildstrom  et al. [2000; high quality] used multiple logistic regression analysis to investigate risk 
factors for persisting POCD at 1-2 years following surgery. Significant risk factors identified were 
age (OR 2.58 [95% Cl 1.42-4.70], ^=0.02), early POCD one week (OR 2.84 [95% Cl 1.35-5.96], 
/?=0.006), and infection within the first 3 postoperative months (OR 2.61 [95% Cl 1.02-6.68], 
/?=0.045).
Four out of five studies did not investigate whether early POCD (at approximately one week) was a 
significant risk factor for POCD at three months [Moller et al. 1998; Canet et al. 2003; Rasmussen et 
al. 2003; Dijkstra et al. 1999]. This would seem important given that the prevalence of persisting 
POCD is not clear from initial analyses; therefore this is a limitation o f the current literature.
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Features o f POCD
Features or patterns o f cognitive deterioration were not reported for any study apart from Dijkstra et 
al. (1999). This may be a result of most studies using z-score transformations between individual 
test scores to calculate POCD, whereby encompassing general deterioration and substantial decline 
in two or more areas o f cognitive functioning [Moller et al. 1998; Abildstrom et al. 2000; Rasmussen 
et al. 2003; Canet et al. 2003; the ISPOCD groups).
Features of POCD found within the Dijkstra et al. (1999) sample encompassed deterioration of 
sensorimotor speed, memory, processing speed o f general information and interference susceptibility 
at one week following surgery. Unfortunately however methodological limitations such as lack of 




Overall, the present review provides substantial support that relatively healthy older adults, with no 
pre-existing cognitive difficulties, who undergo general anaesthetic for major non-cardiac surgery 
are at risk for post-operative cognitive dysfunction at one week and three months post-surgically. At 
1-2 years, persisting POCD was found in <1% [Abildstrom et al. 2000] o f patients suggesting the 
prognosis for an elderly patient with early POCD is good. Methods to determine and define POCD 
are extremely sensitive and reliable if sample sizes are adequately powered to reduce Type II error 
rate. Thus it is recommended that clinicians should consider an acute onset o f cognitive decline, 
supported by reduced performance on neuropsychological tests as resulting from POCD if patients 
have major surgery within three months o f presentation.
However, studies included in this review were considered to have non-representative samples o f the 
older adult or general surgical population as they exclude patients with pre-existing cognitive, 
psychiatric or central nervous system disorders, as well as patients taking tranquillisers or anti­
depressants. Studies have been criticised for this selection bias [Dijkstra & Jolles, 2002], as patients 
meeting these criteria have to attend for surgical procedures as frequently as other individuals. 
There is also evidence that pre-existing deficits predict postoperative cognitive dysfunction or 
exacerbate cognitive decline [Bergren et al. 1987; Chung et al. 1989; Millar et al. 2001; Smith et al. 
1986], thus the true incidence o f POCD may be grossly underestimated. It was also observed that the 
assessment o f POCD did not adhere entirely to the Statement of Consensus Guidelines [Murkin et al. 
1995; 1997] by using inconsistent testing environments and assessing patients one day prior to 
surgery.
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Researchers have therefore asked ‘is POCD a clinical condition or just variability in test 
performance given the lack o f consistency and correlation between test results and subjective 
cognitive complaints’ [Rasmussen et al. 2001]. To investigate this question the ISPOCD group 
conducted a meta-analysis o f four ISPOCD studies (patients n=2536; controls n=359) to examine if 
variability in neuropsychological testing could affect the interpretation o f POCD [Rasmussen et al. 
2004]. They found that test variability contributed to low consistency between postoperative test 
sessions therefore the incidence o f POCD at one week following minor surgery may be due to 
random variation as previously considered, but it did not explain the detection o f cognitive 
dysfunction after major surgery.
Surprisingly, no study stated whether POCD at three months was persisting from one week. This 
raises questions surrounding the appropriateness of defining POCD in patients who have reduced 
neuropsychological test scores at three months when they did not meet criteria for POCD at one 
week, particularly when confounding factors to test performance are likely to be prevalent at one 
week (e.g., pain, hospitalisation, anxiety). It would be difficult to attribute cognitive decline to 
surgical procedures at three months if decline is not evident earlier. Psychological factors such as 
mood, adjustment to a major life experience, or inactivity due to physical recovery may be factors 
contributing to poorer performance on neuropsychological tests, but these have not been examined in 
relation to cognitive functioning. Indeed, the absence of medical risk factors associated with POCD 
at three months may support this hypothesis particularly as mood was not entered into regression 
analyses although considered in the design by four studies.
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In support, some authors proposed that other factors, not controlled for in study design, may have 
contributed to POCD. For example, Canet et al. (2003) suggest the hospital environment induces 
sleep deprivation, immobility, dehydration, and sensory overloading (as POCD was greater at one 
week in the inpatient group compared to outpatients) and Rohan et al. (2005) suggested stress 
responses to surgery, anxiety, and prolonged starvation within the first 24hours, may induce POCD. 
Unfortunately no study has yet examined the effects of psychological factors on the development of 
POCD, particularly as psychological factors may be reduced by psychological intervention thus the 
reduction o f POCD may be viable. Nevertheless, despite mechanisms contributing to POCD 
(neurological dysfunction, motivation, mood, pain etc) remaining unclear because factors such as 
pain, motivation, mood, or fasting, were not controlled for, incidences remain a true reflection of 
POCD. Evidently, older adults are at risk o f cognitive decline postoperatively and this may 
negatively impact on their recovery and quality o f life.
Implications fo r  Future Research
This review highlighted a number o f important areas requiring further examination. For example it 
would be useful to examine the proportion of POCD at three months persisting from one week and 
to examine the contribution o f psychological factors such as mood, anxiety, and stress-response (to 
the hospital environment) to POCD or test variation.
The recent literature has primarily been concerned with the reliability of identifying and determining 
POCD. Now that the literature has resolved many o f its methodological difficulties it is reasonable to 
consider whether statistical differences between groups are also clinically significant [Rasmussen et 
al. 2001]. It is difficult to translate performances on neuropsychological test to functional abilities
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outwith the hospital environment however original examination o f POCD arose from concerns that 
cognitive impairment resulted from surgery and its effect on quality o f life and independence. It 
seems that issues such as psychological or social effects of POCD have been neglected. It is 
recommended that these issues should be considered in future research.
It is widely accepted that when assessing neuropsychological functioning using standardised 
assessment measures that it is necessary to reduce confounding factors as those identified by 
exclusion criteria. However, this results in samples not being entirely representative o f the older 
adult population. Therefore examination o f the effects o f surgery upon cognitive ability in patients 
with pre-existing cognitive, psychiatric or central nervous system disorders, is considered paramount 
to add to the current literature to represent the whole older adult population.
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Chapter 3: M ajor Research Project Proposal
Psychological distress in disease-free breast cancer survivors completing tamoxifen 
therapy: the contribution of illness and treatment representations to psychological
morbidity.
Prepared in accordance with guidelines in the Doctorate in Clinical Psychology Research Training
Folder (see Appendix 3.1)
Leigh Whitnall-Pate 
Section of Psychological Medicine 
Division of Community Based Sciences 
University o f Glasgow




Research has predominately examined patient psychological distress and morbidity during and 
following screening, diagnosis, early treatment, mastectomy, chemotherapy and radiotherapy in 
breast cancer patients. However, psychological morbidity or distress has not been examined in 
patients coming to the end o f tamoxifen therapy, a significant marker in a women’s recovery from 
breast cancer. Anecdotal evidence suggests breast cancer surgeons observe patients to be relieved at 
its discontinuance due to adverse side effects. However, patients have also been observed to be 
extremely anxious when about to complete a 5-year prescription of tamoxifen due to fears of cancer 
recurrence. The current study will examine the variation o f distress related to tamoxifen therapy 
completion in a cohort o f disease-free breast cancer survivors and explore potential relationships 
between treatment representations, illness perceptions, coping style, fear o f recurrence, and 
personality, to variations o f distress.
If the study is successful in identifying psychological characteristics predicting vulnerability for 
psychological distress prior to completing tamoxifen therapy, clinical psychologists in consultation 
with clinical staff can assist and educate relevant health professionals in the routine assessment and 
monitoring of patients to identify those at risk. Clinical psychology could therefore promote the 
psychosocial care o f disease-free survivors through consultation and direct intervention, encouraging 




Breast cancer is the most common incident cancer among women in Scotland and accounts for 25% 
of the female cancer burden excluding non-melanoma skin cancer (National Health Service in 
Scotland, 1998). Being diagnosed at an earlier stage and the use o f systemic adjunctive therapies 
such as chemotherapy and hormonal treatments has improved the likelihood of long-term, disease- 
free survivorship (Ganz et al., 2002; Wingo et al., 1999; Greenlee et al., 2000). Evidently, survival 
from breast cancer has improved over the last 20 years in Scotland, with 56% five year relative 
survival having been reported for those diagnosed between 1968 and 1972 (Black et al., 1993), 
compared to 70% for those diagnosed between 1988 and 1992 (Harris et al, 1998).
Despite increasing numbers o f patients surviving breast cancer, research investigating psychological 
morbidity has typically examined factors impacting on adjustment to the diagnosis or treatment 
(mastectomy, lumpectomy, radiotherapy, or chemotherapy) of breast cancer. During the last decade 
however there has been an increase, albeit small, in research examining breast cancer survivorship 
and the long-term effects on quality o f life outcomes, ranging from 1-10 years follow-up (Bower et 
al., 2000; Dorval et al., 1998; Ganz et al., 1996; Ganz et al., 1998; Ganz et al., 2002).
Adjunctive Hormonal Therapy
Many breast cancer patients who have undergone a surgical procedures, chemotherapy, or 
radiotherapy are prescribed adjunctive hormone therapy i.e., tamoxifen. Five years of tamoxifen 
therapy has been found to reduce the risk o f breast cancer recurrences by 50%, and breast mortality 
by 28%, in women with early stage breast cancer who are estrogen receptor (ER)-positive (Early 
Breast Cancer Trialists’ Collaborative Group, 1998). Although tamoxifen is alleged to reduce the 
incidence o f coronary heart disease (Henderson et al., 1988) and osteoporosis (Turken et al., 1989),
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these additional benefits are outweighed by the knowledge o f serious side effects, such as the 
increase in incidence o f uterine and liver cancers, thromboembolic disease and retinopathy (Fugh- 
Berman & Epstein, 1992), and deterioration in memory when combined with chemotherapy (Bender 
et al., 2005). Due to the negative outcomes associated with long-term administration, women are 
advised that tamoxifen will be prescribed for a maximum of five years. The end o f tamoxifen 
therapy may be viewed as a transition from an ‘acute’ to ‘extended’ stage o f survival whereby the 
patient has finally completed treatment and may have 'watchful waiting' for recurrence or experience 
great anxiety with the diminished contact with the health care team (Mullen, 1985).
Anecdotal evidence suggests that breast cancer surgeons and clinical psychologists have observed 
many patients being relieved or glad to finish tamoxifen therapy due to adverse side-effects 
associated with the drug, such as hot flushes and vaginal discharge, whereas other patients are 
observed to be extremely anxious, worrying that when they stop taking tamoxifen breast cancer will 
recur. Breast cancer survivors, who were disease-free for a minimum of two-years, and diagnosed at 
an earlier stage, were found to significantly believe in the role o f tamoxifen in preventing the 
recurrence of their cancer (Stewart et al., 2001). No study to date has formally examined patient 
cognitions or emotions in relation to completing tamoxifen therapy as research has primarily focused 
on the drug’s effectiveness, side effects, & factors contributing to adherence or early discontinuance. 
Psychosocially, no evidence o f tamoxifen-related side effects have been found on mood, 
psychosocial or sexual functioning in women at high risk of breast cancer (Fallowfield et al., 2001). 
However in a sample o f disease-free breast cancer survivors 5-10 years following primary treatment, 
those treated with chemotherapy, tamoxifen, or both together, were found to be associated with 
poorer functioning on several dimensions of quality of life compared to those who did not receive 
adjunctive therapy (Ganz et al., 2002).
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The psychosocial impact o f changing medication regimes in other clinical populations has also been 
neglected with the primary interest being the examination o f psychological factors contributing to 
medication adherence. Goodacre & Goodacre (2004) found that rheumatoid arthritic patients whose 
disease-modifying anti-rheumatic drugs (DMARDs) were being discontinued, reported having 
increased anxiety, decreased expectations about their outcome, and concerns about running out of 
treatment options. This finding cannot be generalised to breast cancer survivors however given 
tamoxifen is prescribed for the prevention o f a life-threatening disease recurring. Patients coming to 
the end of tamoxifen therapy have no control over its discontinuance, and other clinical populations 
are more likely to have other treatment choices.
Given the high number of women prescribed this risk reducing drug, and the significance of 
completing a 5-year prescription period whilst remaining disease-free, it would appear essential to 
examine psychological distress and factors that may contribute to individual variations of distress. 
This may assist health professionals identify breast cancer survivors who are more vulnerable to 
experience higher levels o f distress than others. ‘Failure to detect and treat elevated levels o f  
distress jeopardises the outcomes o f  cancer therapies, decreases pa tien ts’ quality o f  life, and 
increases health care costs. Psychosocial screening with prospective interventions is a necessary 
component o f  comprehensive cancer care ’ (Zabora, et al., 2001; pp27).
Distress & Adjustment to Cancer
In the largest prevalence study o f distress in cancer patients Zabora et al (2001) found that 32.8% of
breast cancer patients met clinical caseness for distress and one group o f researchers have classified
breast cancer patients an ‘at risk group’ for distress compared to other oncology subgroups
(Herschbach et al., 2004). Despite this, research also suggests that the majority o f women with breast
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cancer are well adjusted (Glanz et al., 1992; Omne-Ponten & Sjoden, 1994; Schover et al., 1995; 
Vickberg et al., 2000). Moderate to high levels o f distress have been evident in the immediate 
aftermath of diagnosis and treatment in breast cancer patients (Fallowfield et al., 1990; Farragher, 
1998; Kissane et al., 1998; Steginga et al., 1998). Varying degrees o f distress have also been 
associated with different stages of breast cancer over a period o f 3-5 years (Heim et al, 1997). 
Helgeson et al (2004) sought to identify distinct trajectories or patterns o f mental and physical 
functioning over 4 years following breast cancer diagnosis and found the course o f adjustment was 
not the same for all patients, with distinct patterns of change, mostly occurring within the first 13 
months of diagnosis. Some women were found to steadily improve with time, whereas others 
showed marked deteriorations or improvements in functioning.
It is evident that factors other than clinical diagnosis and treatment choice contribute to individual 
variations in distress. Factors found to predict greater levels o f distress in individuals in response to 
breast cancer diagnosis and early treatment have been a history o f stressful life events (Butler et al., 
1999), history o f depression (Maunsell et al., 1992), personality (Millar et al., 2005), and fears of 
recurrence (Sneeuw et al., 1992; Mast, 1998, Moyer & Salvoy, 1998; Walker, 1997). Whereas 
factors associated with distress in women at risk for breast cancer include younger age (Lerman et 
al., 1994; Cull et al., 1999), optimism (Audrain et al., 1997), and coping style (Lerman et al., 1996; 
Audrain et al., 1997).
Adjustment to cancer can be defined as an ongoing process where the patient tries to manage
emotional distress and gain control over ongoing cancer-related life events. Greer & Watson (1987)
have identified 5 common adjustment styles to the diagnosis and treatment of cancer which include;
fighting spirit, where the person sees the illness as a challenge and has a positive attitude to outcome;
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avoidance or denial, where the person denies the impact of the disease, and threat from the diagnosis 
is minimised; fatalism, where diagnosis represents a minor threat with no control being exerted over 
the situation and consequences thought to be accepted with equanimity; helplessness and 
hopelessness, where the person is overwhelmed by the enormity o f the threat o f cancer and attention 
bias is on the impeding loss o f life or on the illness as a defeat; and anxious preoccupation, where 
anxiety is the predominant affect filled with compulsive searching for reassurance (Moorey & Greer, 
2002).
A patients adjustment style to breast cancer is therefore hypothesised as a contributing factor to the 
level o f distress found in patients about to complete tamoxifen therapy. Specifically, it could be 
hypothesised that patients with adjustment styles such as fighting spirit, avoidance or denial, and 
fatalism, would experience lower levels of distress when tamoxifen therapy is discontinued 
compared to patients with adjustment styles such as helplessness & hopelessness and anxious 
preoccupation, as patients which the latter adjustment coping styles may be psychologically 
dependent on the risk reduction affects of tamoxifen in relation to cancer recurrence and become 
more distressed when approaching drug discontinuance.
Illness Representations
One theoretical model that has been successful in explaining or predicting psychological distress or 
morbidity in a variety o f patients coping with chronic illness or disease states (cancer, psoriasis, 
rheumatoid arthritis, multiple sclerosis) is Leventhal’s self-regulatory model (SRM; 1984, 1997). 
Leventhal and colleagues proposed that patients’ illness representations (illness cognitions), in order 
to make sense o f illness experience and health threats, are based around distinct components, which 
in turn, determine coping and impact on experiences o f psychological distress and disability
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(Leventhal et al., 1984; Leventhal & Diefenbach, 1991). Illness representation has also been shown 
to predict decisions to engage in screening behaviours and seek health care (Grunfeld et al., 2003) 
and to help with coping successfully with chronic illness (Hampson et al., 1990; Schiaffino, et al., 
1998).
Illness representations are derived from a number of sources, i.e., personal experiences, past 
experience with illness, and information obtained from health and social environments. A meta­
analysis o f empirical studies (n=45) using the model o f illness representations found perceptions that 
the illness is curable/controllable was significantly and positively related to the adaptive outcomes of 
psychological well-being, social functioning and vitality and negatively related to psychological 
distress and disease state (Hagger & Orbell, 2003). Specific to breast cancer, Buick (1997) found 
that illness perceptions were important predictors of psychosocial response to breast cancer 
treatment (radiotherapy & chemotherapy), independent of objective illness severity. Negative 
associations between beliefs over control o f breast cancer and distress have also been shown in 
breast cancer patients (Taylor et al., 1984; Buick, 1997).
The self-regulation model has recently been utilised as a framework to understand individual 
variation in the psychological response to genetic risk o f breast cancer (Rees et al., 2004), which 
provided tentative evidence that both illness perceptions and risk perception contribute 
independently to different aspects of psychological well-being in individuals at risk of disease. It 
would appear sensible to use this model to examine individual variations of psychological response 
in patients completing tamoxifen as patients are likely to have cognitions and expectations of 
favourable outcomes, i.e., less side effects, non-favourable outcomes, i.e., recurrence of cancer, or 
both coming to the end o f treatment.
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Treatment Representations
Another factor that may contribute to distress in patients about to complete tamoxifen therapy is 
beliefs held about their medicine, i.e., their treatment representations. Researchers examining patient 
beliefs about illness recently recommended the separation of illness representations from treatment 
representations to an extended self-regulatory model to better understand patient adherence to 
medicines (Home & Weinman, 2002; Hirani & Newman, 2005). This extended model has been 
successful in predicting medication adherence in other chronic illness populations such as coronary 
heart disease (Byrne et al., 2005), rheumatoid arthritis (Neame & Hammond, 2005), and asthma 
(Home & Weinman, 2002). Horne & Weinman (1999a; 1999b) have shown that beliefs patients 
hold regarding the necessity o f their medication and concerns o f adverse effects o f medications are 
weighed as perceived risks and benefits of treatment which is directly related to their level of 
medication adherence.
Drawing on literature that has examined factors contributing to treatment adherence it may be 
appropriate to hypothesise that patients who have adhered to tamoxifen for over 4.5 years may be 
more likely to hold beliefs that the necessity of their medication outweighs their concerns for 
medication (i.e., adverse side effects), due to recurrence risk reduction. It could also be hypothesised 
that women with higher concerns of tamoxifen therapy will be less distressed coming to the end of 
treatment and women with lower concerns o f tamoxifen may experience higher levels o f distress 
when treatment ends.
Fear o f  Recurrence
Reported earlier, one factor that has been found to contribute to distress in patients is fear of 
recurrence. Percentages o f women with breast cancer reporting fears that their disease will recur
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range from 60-99% (Curran et al., 1998; Noguchi., et al 1993; Pistrang & Barker, 1992; Polinsky, 
1994; Sneeuw et al., 1992). Approximately 70% of survivors still fear the possibility that the disease 
might recur 5 years after diagnosis (Wong & Bramwell, 1992) and one author has suggested that fear 
o f  recurrence is universally present at some level in all patients (O’Neill, 1975). Evidence suggests 
that fears about recurrence are associated with emotional distress among cancer patients (Sneeuw et 
al., 1992; Mast, 1998, Moyer & Salvoy, 1998; Walker, 1997) and has been found to be mediated by 
age and number o f significant others in the patient’s life (Mast, 1998; Northouse, 1981).
Easterling & Leventhal (1989) suggest that two classes o f stimuli may increase the worry about 
cancer; cues related to the events that have been interpreted as threatening or cues that emphasise the 
person’s mortality (i.e., end of tamoxifen therapy). A number o f studies examining the variation of 
distress in women at increased risk o f breast cancer have focused on the accuracy o f risk perception 
and associations between risk perception and the psychological response to risk. These studies have 
suggested that risk perception is positively associated with cancer specific distress (Lerman et al., 
1994; Lloyd et al., 1996; Hopwood et al., 2001; Cull et al., 1999; Watson et al., 1999).
A cognitive model using Leventhal’s SRM of illness was proposed to understand patient reactions to 
the possibility o f recurrence (Lee-Jones et al., 1997) that suggests a patients fear o f recurrence will 
vary depending on their illness representation. It is therefore hypothesised that patients with high 
fears for recurrence will experience higher levels of distress compared to those with lower fears 




Individual differences, other than representations o f illness, treatment, fear o f recurrence, and 
adjustment style, such as an underlying personality style, in particular neuroticism, has been 
postulated to be a contributing factor to health related outcomes as a result o f a patients ability to 
cope with chronic illness (Eysenck & Eysenck, 1985). A review by Williams et al (1997) concluded 
that neuroticism is a vulnerability factor for psychological morbidity and correlates with measures o f 
anxiety (Jerram & Coleman, 1999). Research has shown neuroticism to be a significant predictor of 
intrusive anxiety (Tjemsland et al., 1998), psychiatric morbidity (Farragher, 1998), poor outcome 
(Farragher, 1998), and distress (Millar et al., 2005), in breast cancer patients following diagnosis till 
two years post-mastectomy. It would seem reasonable to hypothesise that patients approaching the 
withdrawal o f tamoxifen who are already neurotic or anxious, as part o f their underlying personality, 
would be more likely to experience psychological distress due to the reduction o f recurrence risk 
when prescribed tamoxifen, if fearful o f recurrence.
Summary o f  Background
It is evident that factors other than clinical diagnosis and treatment choice contribute to individual 
variations o f distress found in breast cancer patients. Factors demonstrated by researchers 
contributing to individual variations in adjustment and distress during various stages of breast 
cancer, have been an individuals adjustment or coping style to their illness, representations of breast 
cancer illness and treatment, personality characteristics, and fear o f cancer recurrence. The degree 
or incidence o f distress found in patients completing tamoxifen therapy, a significant marker in her 
recovery, is not yet known. In addition, it is not clear whether factors known to contribute to distress 
at earlier stages o f breast cancer diagnosis and intervention are relevant during this period and what 




The current study aims to quantify individual variations o f distress in a cohort of women about to 
complete their 5-year prescription period of tamoxifen adjunctive therapy. It is also the aim o f this 
study to explore relationships between illness representations, treatment representations, adjustment 
style to cancer, fear o f recurrence, and personality, to the level o f distress found in women about to 
end their tamoxifen therapy.
(ii) Hypotheses
1. High levels o f distress would be predicted by the nature of treatment representations (lower 
concerns for effects o f tamoxifen).
2. Levels o f distress would be predicted by the nature of illness representations (control/cure & 
timeline acute/chronic).
3. Levels o f distress will be mediated by adjustment to cancer coping style.
4. High scores on neuroticism would be associated with high fears o f recurrence thus associated 
with higher distress.




Patients who attend the breast cancer clinic that have adhered to tamoxifen therapy and are due to 
complete their therapy in 1-6 months time will be invited to take part in the study. Participants will 
have undergone a lumpectomy or mastectomy, chemotherapy or radiotherapy prior to
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commencement o f tamoxifen therapy. Patients will have been disease-free since commencement on 
tamoxifen and will be excluded if they are currently undergoing investigation for cancer, is suffering 
from any other serious illness, learning disability, severe aphasia or where English is not their first 
language.
(ii) Recruitment
Patients meeting inclusion criteria will be identified by the breast cancer clinic administrative 
assistant. Pilot investigations with the clinic indicate that approximately 120 potential participants 
for the study will attend each week. This number is suitable to sample from over a four-month data 
collection period (approximately 1,920 potential participants, taking into account refusals to 
participate, exclusions, & drop-outs).
(in) Measures
To be completed by Researcher 
Demographic & Medical Information
Age, postal code data (to calculate DEPCAT scores for socio-economic status), marital status, pre­
cancer diagnosis medical & psychiatric history, breast cancer treatment history, procedures 
performed, and current medication will be collected from medical notes with patient consent.
To be completed by Participant 
Distress
The Brief Symptom Inventory (BSI; Derogatis & Melisaraatos, 1983), is a 53-item measure of 
psychological distress that contains three global scales and nine subscales. Each item is rated on a 5- 
point Likert scale from 0 (not at all) to 4 (always). Positive cases can be identified by a Global
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Severity Index (GSI) score o f >63 or any two subscales where the 7-score is > 63 (Derogatis, 1993). 
The BSI consistently yields a high sensitivity o f 0.87 and specificity o f 0.89 (Zabora, 1998) and has 
been utilised in prevalence studies related to psychological distress in oncology patients and breast 
cancer populations (Stefanek et al., 1987; Zabora et al., 1990; 2001).
Illness perceptions
The Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris et al., 2002) will be used to 
assess patients’ illness perceptions. It is sensitive to beliefs and cognitions about a wide range of 
chronic illness with a total o f eight subscales addressing the components o f Leventhal’s self- 
regulatory model: illness identity; acute/chronic time-line perceptions; beliefs in severity o f 
consequences; perceptions o f cure or control of the situation; treatment control; illness coherence; 
cyclical timeline perceptions; and emotional representation o f illness. The IPQ-R subscales show 
good internal reliability, and acceptable levels o f stability have been found over 6 weeks and 3 
months (correlations ranging from .46 to .88; Moss-Morris et al., 2002). The IPQ has proved to be a 
significant predictor o f distress in patients recovering from breast cancer prior to its revision (Millar 
et al., 2005).
Treatment representations
The Beliefs about Medicines Questionnaire (BMQ; Horne & Weinman, 1999b) will be used to 
assess patients cognitive representations regarding the necessity o f their medication and concerns 
they have taking it. The scale has been validated for use in patients with chronic illnesses such as 
diabetes, renal failure, rheumatoid arthritis, chronic cardiac disease, and oncology outpatient 
populations (Horne & Weinman, 1999a; 1999b, 2002; Byrne et al., 2005). The BMQ consists of two 
five-item scales assessing patients’ beliefs about the necessity o f prescribed medication for
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controlling their disease and their concerns about potential adverse consequences for taking it. The 
questionnaire is a flexible instrument, which can be adapted by changing the reference statement to 
the desired medication being asked about. A necessity-concems differential can be calculated as the 
difference between the necessity and the concerns scales. The internal reliability o f the scale is 
adequate (Cronbach’s alpha = .88; Byrne et al., 2005).
F ear of recurrence
The Fear of Recurrence questionnaire (Northouse, 1981), a 22-item 5-point likert response scale, 
will be used to assess fears o f recurrence, as this is the only measure o f fear of recurrence in disease- 
free survivors that has reliability data. The scale includes items such as ‘I think about my health 
often’ and ‘I am concerned that the difficulties with my illness may not be over’. The measure has 
been shown to have adequate internal consistency with a small sample (n=30) and has been used 
widely by other researchers to measure fears o f recurrence (Black & White, 2005; Mast, 1998; 
Walker, 1997) in disease-free survivors.
A djustm ent to C ancer Scale
The Mental Adjustment To Cancer Scale (Watson et al., 1988) will be used to assess coping style. 
The scale assesses coping style corresponding to 5 subscales with good internal consistency 
(Cronbach’s alpha), ‘fighting spirit’ and ‘helpless/hopeless’ are amalgamated as they form a bipolar 
scale (.82), ‘fatalism’ (.79), ‘anxious preoccupation’ (.76), and ‘avoidance’ (a single-item measure 
that does not constitute a subscale for scoring purposes).
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Personality
The Short Scale Eysenck Personality Questionnaire -  Revised (EPQ-R; Eysenck & Eysenck, 1985), 
a 48-item yes/no response format questionnaire, will be used to measure the factors o f Psychoticism 
(P), Extraversion (E), Neuroticism (N) and Lie (L), which have been found to be valid, reliable and 
replicable across populations and sexes (McKenzie, 1988). Internal consistency scores range from 
0.62 to 0.88 (Caruso et al., 2001).
(iv) Design & Procedures
This is a cross-sectional questionnaire design. Patients that meet inclusion criteria will be identified 
by breast cancer clinic staff. This is to protect patient data from the researcher prior to consenting to 
participate, in accordance with data protection laws. Patients suitable to take part in the study will 
be sent an information sheet with a covering letter of support from their breast cancer surgeon 2-3 
weeks prior to the patients clinic follow-up appointment. Patients will be asked by their surgeon 
when attending the clinic if they wish to participate in the study and will be able to discuss any 
concerns with the clinic staff prior to meeting with the researcher. Patients that consent will meet 
with the researcher following their clinic consultation. The study will be discussed in full with the 
patient allowing further questions to be addressed prior to taking part. Participants will be asked to 
complete 6 questionnaires taking approximately 20-30 minutes, thanked for their participation, and 
not contacted again. Women identified as having clinically significant levels o f distress or 
psychological morbidity will be offered referral to appropriate services and their breast cancer 
surgeon and general practitioner will be informed in writing.
(v) Settings and Equipment
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Data collection will be carried out in a quiet private room within the breast cancer clinic, at the 
Glasgow Western Infirmary, following participants follow-up consultation. All data will be stored 
in a locked filing cabinet and data stored in a PC database will be protected by password to ensure 
data are confidential. Participants will be allocated identification numbers in order to keep electronic 
data anonymous. The study will not require specialised equipment other than the questionnaires 
stated above, and envelopes.
(vi) Power Calculation
The power calculation for this study was calculated using a two-step formula, proposed by Green
(1991). Green’s (1991) approach is based on Cohen’s (1988) power analytic approach and estimates 
that for a medium effect size i f  = 0.15) with 12 predictor variables (age, socioeconomic status, 
adjustment to cancer (3 scales), fear o f recurrence, neuroticism, treatment representations (2 scales), 
and illness perceptions (3 scales of IPQ-R; timeline acute/chronic, treatment control, personal 
control), the required sample size to test the hypothesis that the population multiple correlation 
equals zero with a power o f .80 (Alpha = .05) will be 1271.
(vii) Data Analysis
Data will be analysed using SPSS version-11.5 for Windows. Data will initially be checked for 
skewness and kurtosis. Data that are not normally distributed will be transformed appropriately. 
Sample characteristics will be defined using descriptive statistics. Preliminary correlational analyses 
will be performed to investigate relationships among fears o f recurrence, personality construct, 
adjustment style to cancer, treatment representations, illness representations, to distress and will
1 Step 1: L= 6.4 + 1.65m- .05m2 therefore L=6.4 + (1.65 X 12) - .05(12)2 therefore L = 6.4 + 19.8 -  7.2 therefore L
= 19
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ascertain which independent variables should be retained for inclusion in the multiple regression. 
Age, social deprivation, neuroticism, fear of recurrence, adjustment style to cancer, beliefs about 
medication, and illness representations, will be entered as explanatory variables in the separate 
multiple regression analyses, having distress (BSI) as the dependant variable
PRACTICAL APPLICATIONS
If the study is successful in identifying psychological characteristics predicting vulnerability for 
psychological distress prior to completing tamoxifen therapy, clinical psychologists can consult and 
educate clinical staff in the routine assessment and monitoring o f patients to identify those at risk of 
distress. Clinical psychology could therefore promote the psychosocial care o f disease-free survivors 
specifically with regard to distress through consultation and direct intervention, encouraging future 
early interventions to reduce tamoxifen related distress, before significantly impacting on quality o f 
life.
TIMESCALE
Main Study Collection -  December to March 2006 
Statistical Analysis -  April 2006 to May 2006 
Write up -  May 2006 to July 2006
ETHICAL APPROVAL
Application for ethical approval will be completed and submitted in November 2005.
Step 2: N  > Li f  therefore N > 19/. 15 therefore N > 126.6666667
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OTHER POTENTIAL PROBLEMS
Participants may be found to have clinically significant levels o f distress during the completion of 
the Brief Symptom Inventory. If this is found to be the case, participants will be given the option for 
referral to appropriate services and their general practitioner and breast cancer surgeon will be 
informed in writing. Reporting beliefs about illness and fears for recurrence may exacerbate levels of 
anxiety or emotional distress surrounding the discontinuance o f tamoxifen. If patients become 
distressed the researcher is trained to reduce acute psychological distress and will ensure the patient 
is psychologically well prior to departure and will be offered referral to appropriate services for 
structured intervention.
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AMENDMENTS TO MAJOR RESEARCH PROPOSAL
Amendments prior to ethical submission
1. Hypotheses stated within the proposal were regarded to be inappropriately directional and 
specific considering the study was investigating questions not previously examined. In addition, 
the overall aim o f the study was to be exploratory in nature and hypotheses stated in the proposal 
would thus be restrictive. Therefore the hypotheses were amended to: 1. a proportion o f patients 
attending their routine breast cancer follow-up appointment would show clinically significant 
levels o f distress when approaching the end o f tamoxifen treatment, and, 2. levels o f distress 
would be predicted by age, cancer treatment history, self reported history o f anxiety or 
depression, socio-demographic factors, and psychological variables (illness and treatment 
representations, adjustment style, fears o f recurrence, and neuroticism). The power calculation 
was not modified prior to recruitment as the number o f variables correlating with distress was 
not yet known.
2. A visit to the breast clinic highlighted that it would be difficult to access patient medical files to 
obtain socio-demographic, cancer treatment history, and medical/psychiatric history, due to time 
constraints between each patient consultation and administration protocols. Therefore it was 
considered that patient self-report using a semi-structured questionnaire administered by the 
researcher would be most suitable method to obtain this information (see Appendix 4.7).
3. It was also considered important for patients to rate how they felt about completing tamoxifen as 
severity o f distress could not be attributed solely to tamoxifen withdrawal. Information was 
obtained by asking patients to rate how anxious, apprehensive, relieved, or positive they were in 
relation to completing tamoxifen using a four-point Likert scale (see Appendix 4.7).
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Amendments following ethical approval
1 .Administrative procedures within the outpatient clinic prevented letters o f invitation to be sent to 
potential participants 2-3 weeks prior to their appointment. Case-notes were only available for 
review between 5-7 days prior to clinic appointment, therefore invitations could only be sent at this 
time. An amendment to the original ethics application was proposed and approved (see Appendix 
3.2).
2 .To reduce participation time the main outcome measure within the proposal to measure severity of 
distress (i.e., Brief Symptom Inventory) was amended to the Brief Symptom Inventory -18. An 
amendment to the original ethics application was proposed and approved (see Appendix 3.3).
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Chapter 4: Major Research Project
Psychological distress in disease-free breast cancer survivors completing tamoxifen 
therapy: the contribution of illness and treatment representations to psychological
morbidity.
Prepared in accordance with requirements for submission to Psycho-Oncology (see Appendix 4.1 for
notes for contributors)
Running head: ‘Predictors o f distress in breast cancer survivors completing tamoxifen therapy’
Submitted in partial fulfilment of the requirements for the Degree of Doctorate in Clinical 
Psychology.
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Great Western Road, Glasgow, G12 OXH, UK. (email: leigh.whitnall@nhs.net) .
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Summary
The current study examined the incidence, and factors contributing to, individual variations of 
distress in a cohort o f disease-free breast cancer survivors about to complete tamoxifen therapy. 
Seventy-two patients, identified through case note review, consented to participate following their 
non-eventful routine follow-up clinic appointment. Six standardised questionnaires were completed: 
the Brief Symptom Inventory-18 (BSI-18), Illness Perceptions Questionnaire- Revised (IPQ-R), 
Beliefs about Medicines Questionnaire (BMQ), Eysenck Personality Questionnaire -  Revised (EPQ- 
R), Mental Adjustment to Cancer Scale (MAC), and Fears of Recurrence Questionnaire (FOR). Six 
percent o f patients showed clinically significant levels of distress when about to complete five-years 
of tamoxifen therapy. Data were examined using correlation and multiple regression analyses. 
Multiple regression predicted fifty-eight percent of the variability in global distress scores after using 
neurotic personality style, concerns about taking tamoxifen, illness perceptions (stronger beliefs 
regarding severity o f consequences, duration, and emotional representations of breast cancer), fears 
of recurrence, and history o f anxiety and/or depression as independent variables. Logistic regression 
analysis was carried out to ascertain predictors to reliably distinguish between self-reported anxious 
and non-anxious patients when about to complete tamoxifen therapy. Our regression model 
significantly accounted for thirty-nine percent o f the variance in feeling anxious or not when about 
to complete tamoxifen with moderate prediction success (72.4% of the anxious patients and 86% for 
non-anxious patients, for an overall success rate of 80.6%). Clinical and research implications are 
discussed in relation to the study findings.
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Introduction
Breast cancer is the most common incident cancer among women in Scotland [National Health 
Service in Scotland, 1998], Evidently, survival from breast cancer has improved over the last 20 
years in Scotland, with 56% five year relative survival having been reported for those diagnosed 
between 1968 and 1972 [Black et al., 1993], compared to 70% for those diagnosed between 1988 
and 1992 [Harris et al., 1998], All women who have oestrogen or progesterone receptor positive 
early stage breast cancer are prescribed tamoxifen therapy as it has been found to reduce the risk of 
breast cancer recurrences by 50%, and breast mortality by 28% [Early Breast Cancer Trialists’ 
Collaborative Group, 1998]. Indeed, breast cancer survivors significantly believe in the role o f 
tamoxifen in recurrence prevention [Stewart et al., 2001]. However due to negative outcomes 
associated with long-term administration (more than five years), such as increased mortality and 
incidence of uterine and liver cancers [Fisher et al., 2001; Fugh-Berman & Epstein, 1992], women 
are advised that tamoxifen will be prescribed for a maximum of five years. When tamoxifen is 
withdrawn, anecdotal evidence from breast cancer surgeons suggest many patients feel extremely 
anxious at this time due to fears o f recurrence. Given the high number of women prescribed 
tamoxifen (70% of breast cancer patients) it is important to examine the incidence of psychological 
distress in this population and examine factors that may contribute to individual variation in distress 
levels.
Breast cancer related distress
Women vary in their emotional responses to diagnosis o f breast cancer. It is acknowledged that pre­
existing individual adjustment styles can mediate emotional responses at time o f initial diagnosis 
[NHMRC; National Breast Cancer Centre, 2000]. Poor adjustment at diagnosis can compromise 
psychological health and result in ‘clinical distress’, encompassing physical, cognitive, and
behavioural symptoms o f anxiety and depression. Furthermore, cancer-related distress can have an
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adverse effect on the patient’s adjustment to future cancer-related events (such as adverse treatment 
protocols). Collectively, between time of diagnosis and up to four years post-surgery, the breast 
cancer population has been found to have a higher prevalence o f distress (40.9%) compared to other 
oncology patients, such as ear nose and throat cancer patients (32.5%), and have thus been termed as 
an ‘at risk group’ for distress [Herschbach et al., 2004], This however may reflect previous findings 
that females routinely report significantly more psychological symptoms and express greater levels 
of distress associated with emotional conflict than males do [Derogatis, 2001].
Despite increasing numbers o f patients surviving breast cancer, research investigating psychological 
morbidity has typically examined factors impacting on adjustment to the diagnosis or early treatment 
o f breast cancer. For example, moderate to high levels of clinical distress have been evident in the 
immediate aftermath of diagnosis and treatment [Zabora et al., 2001; Fallowfield et al., 1990; 
Farragher, 1998; Kissane et al., 1998; Steginga et al., 1998] and found to be associated with different 
treatment and recovery stages [Helgeson et al., 2004; Heim et al., 1997]. The incidence of clinically 
significant distress has been reported as 25-32.8% at diagnosis and early treatment stages [Zabora et 
al., 2001; Glanz et al., 1992] and 16.1% one year following surgery [Millar et al., 2005]. Factors 
found to predict distress severity in response to diagnosis and early treatment are younger age 
[Schag et al., 1993; Tjemsland et al., 1996; Vinokur et al., 1990; Ganz et al., 1993; Herschbach et al., 
2004], a history o f stressful life events [Butler et al., 1999], past psychiatric history [Nosarti et al., 
2002; Maunsell et al., 1992], number o f children under 21 years o f age [Ganz et al., 1993; Schag et 
al., 1993], marital and living status [Omne-Ponten et al., 1992], neurotic personality [Fallowfield et 
al., 1990; Millar et al., 2005], fears of recurrence [Mast, 1998; Walker, 1997] and illness perceptions 
independent o f illness severity [Buick, 1997; Taylor et al., 1984; Millar et al., 2005].
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Other factors that have been associated with severity of distress or poor adjustment throughout 
diagnosis, treatment, and recovery o f breast cancer are social deprivation [Wright et al., 2005; 
MacLeod et al., 2003; Pinder et al., 1993], chemotherapy [Schover et al., 1995], and adjustment style 
[Classen et al., 1996; Cotton et al., 1999; Schnoll et al., 1998; Schover et al., 1995; Grassi et al., 
1993].
Literature examining distress in survivors o f breast cancer (disease-free for five years) is limited as 
studies include women in markedly disparate time frames following diagnosis and typically examine 
‘adjustment’ in relation to quality o f life outcomes, rather than severity of clinical distress. Only one 
study has examined clinical distress in disease-free post-mastectomy breast cancer survivors and 
found that the proportion of high psychological distress at eight years did not significantly differ 
from women never diagnosed with cancer [Dorval et al., 1998]. Age at diagnosis was the only 
predictor o f severity o f distress. Another study reported that approximately 90% of women with 
breast cancer are psychosocially well-adjusted six years after surgical treatment [Omne-Ponten & 
Sjoden, 1994]. When examining the impact o f cancer treatment history to psychosocial adjustment 
in survivors one study found no differences between breast conservation and mastectomy treatment 
groups [Omne-Ponten & Sjoden, 1994]. However in another sample o f survivors, those treated with 
chemotherapy, tamoxifen, or both together, were found to be associated with poorer functioning on 
several dimensions o f quality o f life compared to those who did not receive adjunctive therapy 
[Ganz et al., 2002]. Overall however, in contrast to research examining early outcomes the majority 
of the survivorship literature concludes that there are no major differences in general quality of life 
measures (e.g., fatigue, social adjustment, sexual functioning) between cancer survivors and healthy 
controls [Bower et al., 2000; Dorval et al., 1998; Ganz et al., 1996; Ganz et al., 1998; Ganz et al., 
2002; Meyerowitz et al., 1999]. This may be a result o f adjustment and distress being examined per
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‘time’ post-diagnosis however rather than at time o f clinical events or illness stages as particular 
illness stages, such as recurrence, have been found to be associated with greater distress rather than 
time post-treatment [Heim et al., 1997].
Factors contributing to distress when completing tamoxifen
Psychological responses when completing tamoxifen therapy is currently unknown. Indeed with 
regard to any medication withdrawal, we could only find one study that commented on 
psychological responses to completing disease-modifying medications, which reported that patients 
felt increased anxiety at this time however responses were not formally assessed [Goodacre & 
Goodacre, 2004]. Therefore, in addition to factors predictive o f cancer-related distress cited in the 
literature, psychological models o f chronic illness and medication adherence and models relating to 
individual differences in adjustment style and personality, may further our understanding of distress 
in women completing tamoxifen. These include illness and treatment representations, fear of 
recurrence, adjustment style and personality.
Illness and treatment representations
Leventhal’s self-regulatory model [SRM; Leventhal et al., 1984; 1997] offers a psychological 
interpretation to understanding distress in response to chronic disease. It has been successful in 
predicting distress or morbidity in patients with breast cancer and a variety o f other chronic illnesses 
[Hagger & Orbell, 2003]. Leventhal and colleagues proposed that patients’ illness representations, 
in order to make sense o f illness experience and health threats, are based around distinct 
components. These components are illness identity; acute/chronic time-line perceptions; beliefs in 
severity of consequences; perceptions of cure or control of the situation; treatment control; illness 
coherence; cyclical timeline perceptions; and emotional representation o f illness. It is these
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components that form the patient’s illness cognitions (or beliefs) that determine adjustment and 
experience o f psychological distress and disability [Leventhal et al., 1984; Leventhal & Diefenbach,
1991]. Specific to breast cancer, illness representations are known and important predictors of 
psychosocial response to early treatment whereby negative associations have been found between 
beliefs o f control, perceived duration of illness, and symptom awareness to severity o f distress 
[Taylor et al., 1984; Buick, 1997; Millar et al., 2005]. Subsequently when completing tamoxifen 
therapy beliefs about breast cancer should be considered in relation to psychological responses, 
however individual beliefs about the drug itself may also mediate psychosocial responses.
The separation o f illness representations from treatment representations has recently been 
recommended to increase the understanding o f patient adherence to medicines [Horne & Weinman, 
1999a; Hirani & Newman, 2005], as this has been successful in predicting medication adherence in 
individuals with various chronic illnesses [Byrne et al., 2005; Neame & Hammond, 2005; Home & 
Weinman, 2002]. Beliefs about medicines can encompass those relating to the necessity of the 
medication for health-related outcomes or concerns regarding the medication (due to side-effects or 
dependence). Indeed, older women holding neutral or negative beliefs about the value of tamoxifen 
are more likely to discontinue their prescription within two years [Fink et al., 2004], as are women 
who experience negative side effects [Demissie et al., 2001]. Evidently, it appears that beliefs about 
the risks and benefits o f medicines can be powerful mediators o f adherence and therefore may be 
factors contributing to psychosocial responses when completing tamoxifen. It would seem 
appropriate to hypothesise that concerns related to taking tamoxifen and beliefs surrounding its 
necessity would contribute to, or mediate, an individuals psychological response when completing a 
five-year prescription. For example, patients who have complied with a five-year prescription
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(despite experiencing negative side effects) may hold stronger beliefs regarding its necessity and 
thus experience higher levels o f distress on completion.
Fear o f  breast cancer recurrence
As reported earlier, research has shown that fears about recurrence are associated with emotional 
distress among cancer patients [Sneeuw et al., 1992; Mast, 1998, Moyer & Salvoy, 1998; Walker, 
1997]. Incidence reports suggest that 60-99% of breast cancer patients fear recurrence of disease 
[Curran et al., 1998; Noguchi et al., 1993; Pistrang & Barker, 1992; Polinsky, 1994; Sneeuw et al.,
1992] and approximately 70% of survivors still fear the possibility that the disease might recur five 
years after diagnosis [Wong & Bramwell, 1992]. Easterling and Leventhal [1989] suggest that two 
classes of stimuli may increase the worry about cancer recurrence; cues related to the events that 
have been interpreted as threatening or cues that emphasise the person’s mortality. The completion 
of tamoxifen and beliefs surrounding its disease-modifying quality may be interpreted as such a cue, 
thus increasing distress.
Adjustment style
Adjustment to cancer can be defined as an ongoing process where the patient tries to manage 
emotional distress and gain control over ongoing cancer-related life events. Greer and Watson 
[1987] have identified five common adjustment styles to the diagnosis and treatment o f cancer; 
fighting spirit, avoidance or denial, fatalism, helplessness and hopelessness, and anxious 
preoccupation [Moorey & Greer, 2002]. Certain adjustment styles, such as fighting spirit, are 
associated with lower levels o f distress in breast cancer patients [Classen et al., 1996; Cotton et al., 
1999; Ferrero et al., 1994; Schnoll et al., 1998] and adjustment styles representative of 
hopelessness/helplessness, anxious preoccupation, and fatalism are associated with higher levels of
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distress [Grassi et al., 1993; Schover et al., 1995]. Therefore it would be reasonable to consider 
adjustment style as a mediator o f distress when completing tamoxifen, a significant cancer-related 
event.
Personality style
Individual differences, such as an underlying personality style, have also been postulated to be a 
contributing factor to health related outcomes related to patients’ ability to adjust with chronic illness 
[Eysenck et al., 1985]. A neurotic personality style contrasts traits such as nervousness, moodiness, 
and sensitivity to negative stimuli with coping ability [Rathus & Nevid, 2005, p.62]. Research has 
shown neuroticism to be a significant predictor of intrusive anxiety [Tjemsland et al., 1998], 
psychiatric morbidity [Williams et al., 1997], and poor outcome [Farragher, 1998]. Specific to 
breast cancer, neuroticism has been found to be a predictor of distress at time o f diagnosis and up 
and two years post-mastectomy [Millar et al., 2005]. Given the evidence to suggest that personality, 
and in particular neuroticism, can mediate the development o f distress it would be important to 
examine its contribution to severity of distress in patients when approaching completion o f 
tamoxifen.
The current study
The current study aimed to quantify individual variations of distress in a cohort of women about to 
complete their five-year prescription period of tamoxifen adjunctive therapy when attending their 
routine six-month breast cancer follow-up appointment. Furthermore, it aimed to determine whether 
factors previously associated with breast cancer distress, at various stages o f illness and recovery, are 
also significant predictors o f distress at this time. In addition, it was also intended to explore the
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contribution o f treatment representations further (i.e., beliefs regarding tamoxifen), to variations of 
distress.
Hypotheses
1. A proportion o f patients attending their routine breast cancer follow-up appointment would 
show clinically significant levels o f distress when approaching the end of tamoxifen 
treatment.
2. Levels of distress would be predicted by age, cancer treatment history, self reported history 
of anxiety or depression, socio-demographic status, and psychological variables (illness and 
treatment representations, adjustment style, fears o f recurrence, and neuroticism).
Method
Participants
A power calculation was used to ascertain the sample size required for multiple regression for twelve 
predictor variables using a two-step formula proposed by Green [1991]. Green’s [1991] approach is 
based on Cohen’s [1988] power analytic approach and estimates that for a medium effect size { f  = 
0.15) with twelve predictors to test the hypothesis that the population multiple correlation equals 
zero with a power o f .80 (Alpha = .05) would be 127.
Seventy-two patients were recruited by means of continuous sampling from patients who attended a 
6 monthly follow-up outpatient clinic at a local breast cancer service, Western Infirmary, Glasgow. 
Patients were eligible to participate if they were about to complete tamoxifen in one to six months 
time, were not continuing with further adjuvant hormonal therapy (Letrazole), had been disease-free
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since commencement on tamoxifen and were not experiencing any other major psychiatric or 
neurological disease.
Procedure
The present study gained ethical approval from Greater Glasgow Primary Care NHS Health Board 
and North Glasgow Hospitals University NHS Trust (see Appendix 4.2). Patients were identified as 
suitable participants from weekly case note file reviews by a specialist breast care nurse. Prior to 
attending their appointment suitable participants were sent an introduction letter (see Appendix 4.3) 
and information sheet (see Appendix 4.4) by their consultant and invited to participate. Following a 
non-eventful clinic appointment, patients were asked by their attending physician if they had 
questions regarding the study and wished to participate. On obtaining written consent (see Appendix 
4.5) patients were interviewed individually by the lead investigator in a private room in the clinic. 
Cancer treatment and medical history, psychiatric history, and socio- demographic information were 
obtained by patient report. Patients were asked to complete six self-report psychometric assessment 
measures (detailed in the Materials section below). All participants completed the questionnaires 
during their outpatient visit. Patients meeting clinical caseness for distress were offered referral to 
psychological services and their GP and breast surgeon were notified in writing.
Materials
Distress
The Brief Symptom Inventory -  18 [BSI-18; Derogatis, 2001], an eighteen-item instrument is a 
highly sensitive and efficient screen for psychiatric disorders and psychological distress in medical 
and cancer patients [Zabora et al., 1990; Zabora et al., 2001; Carlson & Bultz, 2003]. The instrument 
yields three subscale scores: Somatisation, Depression and Anxiety, which compile a composite
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score indicating severity o f distress termed ‘Global Severity Index’ (GSI). Internal consistencies 
range from .74 to .89. Extensive normative data for oncology and community populations is 
available.
Illness representations
The Revised Illness Perception Questionnaire (IPQ-R) [Moss-Morris et al., 2002] is a questionnaire 
sensitive to beliefs and cognitions addressing the components o f Leventhal’s self-regulatory model. 
The IPQ-R subscales show good internal reliability, correlations ranging from .46 to .88 [Moss- 
Morris et al., 2002].
Treatment representations
The Beliefs about Medicines Questionnaire - Specific (BMQ) [Horne & Weinman, 1999b] is 
sensitive to beliefs surrounding the necessity of a medicine and concerns when taking it. The 
questionnaire is a flexible instrument, which can be adapted by changing the reference statement to 
the desired medication being asked about. Questions include ‘without tamoxifen I would be very ill’ 
and ‘I worry about becoming dependent on tamoxifen’. Consisting o f two five-item Likert scales the 
internal reliability o f the scale is adequate [Cronbach’s alpha = .88; Byrne et al., 2005].
Fear of recurrence
The Fear o f Recurrence questionnaire [Northouse, 1981] is a twenty-two-item five-point Likert 
response scale measuring severity o f recurrence fear. The measure has been shown to have 
reliability (Cronbach’s alpha coefficient of .92) [Hilton, 1989], content validity [Northouse, 1981], 
and has been used widely by other researchers to measure fears o f recurrence [Black & White, 2005; 
Mast, 1998; Walker, 1997] (see Appendix 4.6).
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Adjustment Style
The Mental Adjustment to Cancer Scale [Watson et al., 1988] is a measure designed to assess an 
individuals’ adjustment style corresponding to Greer and Watson’s [1987] framework. Consisting of 
five subscales; ‘fighting spirit’ and ‘helpless/hopeless’ are amalgamated as they form a bipolar scale 
(Cronbach’s alpha .82), ‘fatalism’ (.79), ‘anxious preoccupation’ (.76), and ‘avoidance’ (a single­
item measure that does not constitute a subscale for scoring purposes), the scale demonstrates good 
internal consistency [Watson et al., 1988].
Personality
The Short Scale Eysenck Personality Questionnaire -  Revised (EPQ-R) [Eysenck et al., 1985], a 
forty-eight-item yes/no response format questionnaire, measures the personality style of neuroticism. 
Internal consistency scores range from .62 to .88 (Caruso et al., 2001).
Socio-demographic and clinical information
Age, postal code (to calculate DEPCAT scores for socio-economic deprivation status), number of 
dependants, psychiatric history, and breast cancer treatment history, was provided by patient report 
using a semi-structured questionnaire (see Appendix 4.7). Patients were also asked ‘how would you 
describe how you feel about stopping tamoxifen therapy?’ Patients rated four psychological 
responses on a four-point Likert scale (not at all; a little; some; a lot); for feeling apprehensive, 
positive, anxious, and relieved.
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Statistical Analysis
Prior to analysis, all continuous variables were examined for accuracy o f data entry, missing values, 
and fit between their distributions and the assumptions o f multivariate analysis (skewness, kurtosis, 
and homogeneity o f variance). The internal consistency and distributions o f scales were checked 
before performing bivariate analyses. Missing values for MAC subscales were replaced by the mean 
for all cases as missing cases were less than 5% of total cases and did not differ significantly from 
the sample on any other variable. Three univariate outliers were identified because of their 
extremely high scores on the BSI-18 Global Severity Index (GSI). Data for the three cases were 
compared to the complete data set. Examination o f univariate outliers did not highlight unusual 
characteristics and were considered to be from the intended population. Transformation failed to 
normalise distribution therefore outlier scores were changed to be one unit above the next highest in 
the data set accordingly [Tabachnick & Fidell, 2001; Field, 2005] to achieve normal distribution 
(using Kolmogoroc-Smirnov Z test). No multivariate outliers were identified through Mahalanobis 
distance. Preliminary correlational analyses were performed to investigate relationships between age, 
socio-demographic status, psychological variables, and distress using Spearman and Pearson 
correlation coefficient. Preliminary independent t-tests were performed to investigate differences 
between those reporting feeling anxious or not when about to complete tamoxifen. Multivariate 
analyses were employed to examine relationships between independent variables and distress and 
whether reporting feeling anxious or not at completing tamoxifen.
Results
Data completion
O f 95 patients invited to participate, 13 were not suitable to take part in the study due to: cognitive 
decline (1); intended for continued adjuvant hormonal therapy (10), or stopped tamoxifen
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prematurely (2). O f 82 patients suitable to participate 72 took part as 10 refused (12.2%) due to time 
constraints when attending the clinic.
Patient Characteristics
The demographic characteristics o f the 72 patients are illustrated in Table 1.
[Insert Table 1. here]
Sample characteristics were compared to the Scottish breast cancer population diagnosed in 2001. 
Mean age at diagnosis (M=58.86 SD= 9.89) was similar to that o f the general Scottish breast cancer 
population (M=63.2, SD=14.4) [Scottish Cancer Registry, 2006]. Two thirds of the sample had 
DEPCAT scores o f 4 to 7, reflecting the prevalence of socio-economic deprivation in the sample, 
however this is similar to other breast cancer research populations in Glasgow [Millar et al., 2005]. 
Therefore the sample is considered to be representative o f the Scottish breast cancer population.
Assessment o f  Psychological Distress
Mean score and standard deviation for psychological measures are shown in table 2. The mean T 
score for the Global Severity Index (GSI) measuring distress (BSI-18) was 44.64 (S.D 10.0). Only 
four (6%) patients met clinical caseness for psychological distress (T score >63 on GSI or two 
subscale T scores > 63) above community population norms [Derogatis, 2001].
[Insert Table 2. here]
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A number of statistical tests were undertaken to examine potential relationships between the 
psychological outcome measure (GSI), cancer treatment history, history o f self-reported anxiety 
and/or depression, and socio-demographic status. No significant relationships were found between 
distress and age (Pearson correlation, two-tailed), number o f children under 21 years (Pearson 
correlation, two-tailed), or social deprivation (DEPCAT; Spearman rank correlation, two-tailed). 
Mean distress scores did not differ according to living or marital status (independent samples t-test, 
two-tailed) or cancer treatment history (one-way ANOVA). Mean distress scores significantly 
differed between those who reported a history o f anxiety/depression to those who did not (t= 4.529 
df=70, /K .001), with higher distress scores found for those reporting a history o f anxiety and/or 
depression.
Further preliminary correlation analyses were carried out to examine co-linearity among independent 
psychological variables (illness representations, treatment representations, adjustment style, fear of 
recurrence, and neuroticism), and to ascertain which variables should be retained for inclusion in the 
multiple regression analyses. Table 3 summarises significant relationships between psychological 
variables.
The strength o f relationships between independent variables (e.g., illness representations, 
personality, beliefs about medicines and fear of recurrence) and distress ranged from medium to 
large. As would be expected a high positive correlation was found between global distress and 
neuroticism, (r=.596, /K .001). Correlations between the scales on the IPQ-R and distress showed 
that stronger beliefs that breast cancer would last a long time (timeline acute/chronic), had serious 
consequences, and strong emotional representations o f breast cancer were significantly associated
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with higher levels o f psychological distress when about to complete tamoxifen (r=.307; p= .008/ 
r=.550, .552; /?<.001; respectively).
There were also medium positive correlations between concerns about tamoxifen, fears o f 
recurrence, and distress (r= .423, .473; /?<.001, respectively). No significant correlations at the 0.01 
level were found between distress and adjustment style (MAC subscales), beliefs regarding medicine 
necessity, and breast cancer representations of personal control, treatment control, and illness 
coherence.
[Insert Table 3. here]
No variables were considered for exclusion from the multiple regression analyses as no two 
independent variables had a bivariate correlation of 0.7 or more as recommended by Tabachnick and 
Fidell [2001, p.83].
Predicting psychological distress
A standard multiple regression was performed between distress (GSI) as the dependant variable and 
seven predictor variables: self-reported history o f anxiety and/or depression, neuroticism, concerns 
about taking tamoxifen, fears o f recurrence, and illness representations o f breast cancer (timeline, 
consequences, emotional representation). Table 3 displays the correlations between the variables,
the unstandardised regression coefficients (B), the standardised regression coefficients (P), the
2 2 2 semipartial correlations (sri ) and R , and adjusted R . R for regression was significantly different
from zero, F(7, 64) = 12.674, j?<.01. Only three o f the independent variables contributed
significantly to prediction of global distress; neuroticism score (5%), IPQ-R consequences score
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(8%), and self-reported history o f anxiety and/or depression (5%). The seven independent variables 
in combination contributed another 40% in shared variability. Altogether, 58% (54% adjusted) of 
the variability in global distress scores was predicted by knowing scores on these seven variables.
[Insert Table 3. here]
Anxious vs. Non-anxious self-report when completing tamoxifen
Only four participants met clinical caseness for distress (GSI) when about to complete tamoxifen, 
however in contrast, twenty-nine participants (40%) rated themselves as feeling anxious to some 
degree on a four-point Likert scale (scores were recoded into two groups: those who reported feeling 
a little, some, or a lot o f anxiety were classified as feeling ‘anxious’ and those reporting no anxiety at 
all classified as ‘non-anxious’). Further analyses were therefore considered important to examine 
potential differences between anxious and non-anxious groups and to ascertain if clinical, socio­
demographic, or psychological variables were predictors of group membership. Anxious and non- 
anxious groups were compared on socio-demographic, self-reported history o f anxiety and/or 
depression, and cancer treatment history using crosstabulation Chi-Square tests. Independent sample 
t-tests for continuous data were used to examine differences between groups on psychological 
measures and age.
The anxious group were found to have a higher incidence of self-reported history o f anxiety and/or 
depression (34% vs. 13%; x2= 5.49, df=l,/?=.019) and higher global distress scores (GSI; t= 2.763, 
df= 70, p=0.007) compared to the non-anxious group. Mean age did not differ between groups. 
Significant differences between groups on psychological continuous variables are shown in table 4. 
It is evident that those who reported feeling anxious about completing tamoxifen therapy had
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significantly higher neuroticism scores, stronger concerns related to taking tamoxifen, stronger 
beliefs surrounding the necessity o f tamoxifen, greater fears o f recurrence, stronger emotional 
representations o f breast cancer, and higher scores o f anxious preoccupation adjustment style.
[Insert Table 4. here]
A direct logistic regression analysis was performed with self-reported anxiety about completing 
tamoxifen as the outcome variable, with one clinical history predictor (self-reported history of 
anxiety/depression), and seven psychological predictors: distress, neuroticism, fear o f recurrence, 
beliefs about medicines (concerns and necessity), emotional representation o f breast cancer, and 
anxious preoccupation adjustment style. A test of the full model with all eight predictors against a 
constant-only model was statistically reliable, x2 (8, n=72) = 38.082 /?<.001, indicating that the 
predictors, as a set, reliably distinguished between self-reported anxious and non-anxious patients 
when about to complete tamoxifen. Calculation o f R2 indicates that the model can account for 39% 
of the variance in feeling anxious or not when about to complete tamoxifen. Prediction success was 
moderate with 72.4% of the anxious patients and 86% for non-anxious patients, for an overall 
success rate o f 80.6%. Table 5 shows the beta values and their standard errors, Wald statistics, Exp 
B, and 95% confidence intervals for Exp B, for each o f the eight predictors. According to Wald 
criterion however, none of the eight predictors reliably predicted self-reported anxiety. Although not 
statistically significant at the 0.05 level there was a trend towards beliefs surrounding the necessity 
of tamoxifen contributing to feeling anxious when about to complete therapy.
[Insert Table 5. here]
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Discussion
The primary aim o f this study was twofold. Firstly, we sought to identify the prevalence of clinical 
distress in a sample o f disease-free breast cancer survivors about to complete adjunctive tamoxifen 
therapy. Secondly, we aimed to examine the contribution o f individual factors to variations of 
distress, such as beliefs about tamoxifen and other factors known to be contributors to distress at 
earlier stages o f breast cancer. The current study is the first to report the incidence o f clinical 
distress in disease-free breast cancer survivors at five-years and in those about to complete 
tamoxifen.
There was support for the first hypothesis as 6% of our sample showed clinically significant levels of 
distress when about to complete five-years of tamoxifen therapy. The incidence o f distress found 
within this sample is lower than incidences found during early treatment (25 to 32.8%) and one-year 
post-surgery incidences (16.1%). Due to the heterogeneity o f methods measuring clinical distress 
and the duration o f disease-free status we are unable to compare our findings to the only other study 
examining distress in breast cancer survivors at eight years [Dorval et al., 1998]. Nevertheless, the 
small incidence o f those meeting caseness for distress supports previous research findings that 
approximately 90% o f disease-free survivors are psychosocially well-adjusted after surgical 
treatment [Omne-Ponten & Sjoden, 1994].
There was partial support for the second hypothesis. When factors associated with severity of 
distress were entered into multiple regression analyses only illness perceptions (perceived 
consequences resulting from breast cancer), neuroticism, and self-reported history o f anxiety and/or 
depression, significantly accounted for individual variation o f distress (18%) in addition to four other 
variables (40%; fears o f recurrence, concerns about taking tamoxifen, emotional and timeline
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representations o f breast cancer). There was only partial support as age, socio-demographic status, 
cancer treatment history, adjustment style, and beliefs surrounding the necessity of tamoxifen were 
not found to be associated with levels of distress as predicted. Variables such as age and social 
deprivation were not associated with distress at five years and may be a consequence of the sample 
being relatively older (as the majority of hormone receptor positive breast cancers occur in post­
menopausal women) and having higher levels of social deprivation compared to previous studies 
that include hormone receptor negative and positive breast cancer patients. The majority of our 
sample was also married with few children aged less than twenty-one years. The finding that cancer 
treatment history was not associated with distress supports previous findings in the survivorship 
literature [Omne-Ponten & Sjoden, 1994]. Reasons for adjustment style not being associated with 
distress using bivariate correlations may be an indication that the MAC scale was not suitable for our 
sample, as it encompasses constructs theorised to be adjustment styles to cancer, and survivors may 
not perceive themselves as having to ‘adjust to cancer’ due to their disease-free status.
Our finding that beliefs surrounding the severity o f consequences from breast cancer predicted 
severity of distress (e.g., ‘breast cancer is a serious illness’ and ‘breast cancer has major 
consequences on my life’), may suggest that despite time post-treatment and disease-free status 
consequential beliefs are artefacts of the collective breast cancer experience throughout diagnosis, 
treatment, and recovery. This may be attributable to actual negative outcomes following breast 
cancer related-events e.g., having to take early retirement due to fatigue or significant levels of 
distress resulting in poor adjustment at earlier stages of diagnosis/treatment. Indeed, illness 
perception components found to predict distress at earlier stages o f breast cancer treatment (such as 
beliefs o f control), but not at five-years, may suggest that beliefs surrounding breast cancer may 
change over time and that early beliefs may not pertain to disease-free survivors due to perceptions
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that breast cancer is not a current illness. Our findings provide additional support to Horne & 
Weinman’s [1999a] premise that the separation o f treatment and illness representations is useful, not 
only when examining adherence to medication, but also when examining psychological responses to 
completing tamoxifen therapy.
Forty-two percent of the variance in distress was unexplained by our model. One possible reason for 
this would be that a proportion o f distress expressed is pre-existing or related to non-cancer-related 
events, factors not measured or controlled for in the current study. For example, women were not 
asked whether they were experiencing any current major life events at time o f participation and this 
may have been a contributing factor as a history o f other stressful life events [Maunsell et al., 1992] 
and current marital/sexual problems [Pistrang & Barker, 1995] have both been shown to be 
predictive to severity o f distress.
Following descriptive examination of the data it was also evident that the prevalence o f clinical 
distress was disproportionate to the number of women who reported feeling anxious at the prospect 
of completing tamoxifen. It was therefore questioned if distress could be attributed to the event 
being examined (i.e., psychological response to tamoxifen withdrawal), as cross-sectional designs 
cannot indicate whether distress was pre-existing, or if it was an indication o f individual variation in 
psychological response severity to the event. We therefore compared women who reported feeling 
anxious at completing tamoxifen to those who did not and found interesting results. For example, 
factors that were associated with severity o f distress e.g., reported history o f anxiety and depression, 
neuroticism, fears o f recurrence, concerns regarding tamoxifen, and emotional representations of 
breast cancer, were also found to be stronger within women who reported feeling anxious in relation 
to completing tamoxifen. Contrastingly, factors not associated with distress e.g., beliefs regarding
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the necessity o f tamoxifen and anxious preoccupation adjustment style, were found to significantly 
differ between women who reported feeling anxious or not, with the anxious group having higher 
scores on both variables. This may offer some support to our hypothesis that levels o f distress may 
not be attributable to completing tamoxifen per se and should be examined further using a 
longitudinal design.
Although no one predictor was identified as statistically contributing to predicting whether a woman 
was anxious or not at completing tamoxifen there was a trend towards those with stronger beliefs 
surrounding the necessity o f tamoxifen to report feeling anxious or not. Indeed, this would seem 
reasonable as women who remain disease-free may attribute their health status to tamoxifen as it is a 
recurrence-reduction medication and they would understandably be anxious at its withdrawal. 
However a larger sample would be required to examine this hypothesis further.
Methodological Limitations
One o f the major limitations of the current study was that the sample size was insufficient to meet 
initial power calculation requirements for twelve predictor variables. Although only seven variables 
were entered in to multiple regression analyses the sample size remains underpowered using certain 
power calculations [Green, 1991]. However other papers state that for seven predictors a sample 
size of 57 would suffice [Harris, 1975] or at least five participants per predictor would be required 
[Tabachnick & Fidell, 1989]. Nevertheless it is possible that our results are vulnerable to Type II 
error, in both regression analyses, and variables not identified as contributors to distress, or feeling 
anxious when completing tamoxifen, may have been unidentified (adjustment style, beliefs 
regarding necessity o f tamoxifen).
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It is acknowledged that the BSI-18 may not be sensitive to cognitive worries in breast cancer 
survivors as some factors associated with feeling anxious were not associated with levels o f distress. 
However this may also be a reflection o f the severity o f psychological responses in survivors 
whereby it may be anxiety provoking to complete tamoxifen but perhaps much less so in comparison 
to a diagnosis o f breast cancer or invasive and traumatic treatment protocols. In addition, the 
method used to classify whether a woman felt anxious or not at completing tamoxifen in the current 
study can be viewed as arbitrary. Therefore it could be argued that the study may have benefited 
from the inclusion o f questionnaire specifically measuring degree o f worry or anxiety when about to 
complete tamoxifen. This however would have involved devising such a measure, and ensuring its 
reliability and validity, which was not possible given the time constraints in conducting the study.
It is also acknowledged that the cross-sectional nature of the study only allows for the analysis 
between distress and psychological factors at a single point in time, thus necessitating some caution 
in the interpretation o f results and inferences about their direction. Nonetheless, the investigation 
has important implications for the breast cancer population and provides a scientific framework to 
explore and discuss the anecdotal experiences of clinicians working in this field. Furthermore given 
the advances in recurrence reduction therapy such as Letrazole, a new pharmaceutical extending 
adjuvant medication for three years following tamoxifen withdrawal, it would be important to 
consider the findings o f this study and others that will follow when women approach the end of long 
term (eight years post diagnosis) pharmaceutical therapy.
Clinical & Research Implications
The current study was undertaken as observations from breast surgeons suggested women felt 
anxious and experienced high levels o f distress when about to complete tamoxifen therapy. We have
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confirmed this clinical impression using formal measures o f distress and self-report. As this is the 
first study to examine psychological responses in women about to complete tamoxifen therapy, and 
indeed withdrawal o f any medication, clinical implications are preliminary until our findings can be 
replicated with a larger sample size thus addressing the aforementioned methodological limitations. 
If  our results are replicated then service provision requirements for the management o f distressed or 
anxious patients at time o f competing tamoxifen should be considered locally however it would be 
beneficial to increase awareness o f factors predictive o f distress and anxiety to assist in the early 
identification and management o f patients. In the interim we recommend that during routine clinic 
follow-up appointments, breast surgeons, general practitioners, and breast cancer care sisters, should 
consider asking patients how they feel about completing their tamoxifen therapy in order to address 
any concerns or anxieties patients may have at this time. This may be especially important when 
patients are fearful o f recurrence and are unaware that continuance o f tamoxifen beyond five years 
increases mortality and risk for cancer recurrence.
It was disappointing to find that neuroticism, a stable personality characteristic [Eysenck & Eysenck, 
1991], and a reported history o f anxiety and/or depression predicted distress, as neither factor can be 
altered by psychological intervention. However, it was encouraging that the largest predictor of 
distress in the current sample were beliefs regarding severity o f consequences of breast cancer as 
these may be mediated using psychological intervention, thus reducing distress.
In conclusion it would seem that the psychological responses o f patients to the withdrawal of 
medications has been neglected within the clinical and research community with medication 
adherence taking precedence. It is hoped that the current research will initiate other researchers to 
examine our findings further in breast cancer survivors and in other populations that are prescribed 
time-limited medications, such as chronic heart failure or rheumatoid arthritis patients.
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TABLE 1. Demographic characteristics, deprivation category (DEPCAT), and clinical 
treatment history o f study participants (n=72)









With others 58 (80.6)
Alone 14 (19.4)












Lumpectomy only 1 (1.4)
Mastectomy only 13 (18.0)
Surgery + Adjuvant 58 (80.6)
(chemotherapy/ rad iotherapy)




TABLE 2. Global Severity Index of Distress in BSI-18; IPQ-R; Beliefs about Medicines 
Questionnaire; MAC; EPQ-R; and Fears of Recurrence mean scores.
Mean SD
BSI-18
Global Severity Index (GSI) o f Distress T score 44.64 10.00
IPQ-R
Acute/Chronic Timeline 14.67 3.26
Consequences 17.10 4.00
Personal Control 19.22 4.16
Treatment Control 20.78 2.27
Illness Coherence 19.36 3.44
Timeline Cyclical 8.68 2.47
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Chapter 5: Single Case Research Study A bstract
The contribution of performance anxiety to processing efficiency in a 
cardiac patient with impaired processing speed
Prepared in accordance with requirements for submission to Neurocase 
Running head: ‘Impact o f performance anxiety to processing speed’
Address for Correspondence: Leigh Whitnall-Pate, Section o f Psychological 
Medicine, D ivision o f Community Based Sciences, University o f Glasgow Academic 
Centre, Gartnavel Royal Hospital. 1055 Great Western Road, Glasgow G12 OXH, 
UK. email: Leigh.W hitnall@ nhs.net




In this paper we investigate the contribution o f performance anxiety to impaired 
processing efficiency according to Eysenck & Calvo’s (1992) model o f processing 
efficiency in a cardiac patient using an experimental design. Objective (mean pulse 
rate) and subjective measures (cognitive interference and anticipatory anxiety) o f 
performance anxiety indicated lower performance anxiety was associated with greater 
processing speed. Difficulties with interpreting impaired neuropsychological test 
scores in performance-anxious individuals are discussed and recommendations are 
made for future research. Clinical implications regarding the adverse impact of 
performance anxiety on neuropsychological test performance are also discussed in 
relation to the current limitations surrounding the interpretation o f neuropsychological 
assessment scores.
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Appendix 1.1: Discharge coding sheet
Departm ent of Psychological Services and Research 
COMPUTER CODING SHEET
Date R ef R ec ................................. (Day, Month, Y ear)................._ [  ] [  ] [  ] [  ] [  ] [  ]
D.O.BJCH1 No........................................................................................................ [ /  ]




1) Less 6 ninths 2) 6 m nths-I year 3) I year or more 4) Not R a ted   [ j
S ev erity :
1) Mild 2) M oderate 3) Severe 4) Not Rated ............  .  ( ]
C om plexity:
I) Not Complex 2) Low Degree 3) Moderate 4) High Degree 5) Not R a te d ... .   J J
Specialty: 1) Adult M ental Health 2) Elderly 3) Learning Disability 4) Neuro 5) Forensic 
6) General Medicine 7) Addiction/Substance Misuse 8) Other   [ ]
DISCHARGE SECTION
O utcom e 1) Much Imp 2) M od Imp 3) SI Imp 4) Unchg 5) Dct 6) Much Det
7) DNA 8) Seen l/A ssess 9) Never Seen 0) Other   [ ]
Standard Discharge Reason ... 1) Did not opt in 2) Died 3) Failed to attend 4) Never seen | |
5) No further im provem ent possible 6) Parental/client request 7) Problems resolved 
8) Transfer to another clinician 9) Transfer to another area 10) Transfer to another 
agency 11) Treatm ent com plete 12) Unable to attend 13) Inappropriate referral
Date o f Discharge (Day, M onth, Y e a r).....................................................................[ ] [  ] [  ] [  ] [  ] [  ]
Number of attendances I 1
Appendix 1.2: Differences between geographical area, referring agents and age. 
TABLE 1. Mann Whitnev-U Test Results: between geographical areas and age of referral.
AREA COMPARED Statistical Result
AE vs. NU U= 132948.500, /?=0.430
AE vs. WG U= 30218.000, p=0.317
AE vs. ST U=28376.000, p= 0 M 2
NU vs. WG U= 34933.00, p=0.574
NU vs. ST U= 30904.00, p=  0.056
WG vs. ST U=7005.000, p=  0.057
Significance level usedp< 0.00083, calculated using the bonferroniprocedure
TABLE 2. Mann Whitnev-U Test Results: between referring agents and age of referral.
REFERRING AGENTS COMPARED Statistical Result
GP vs. CMHT U= 58981.000, /?=0.840
GP vs. PMP U= 49432.000, p=0.031
CMHT vs. PMP U= 6468.500, /?=0.146
Significance level used p<0.017, calculated using the bonferroni procedure
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Appendix 1.3: Differences between geographical area, referring agents, and number of sessions
attended.
TABLE 1. Mann Whitnev-U Test Results: between geographical area and number of sessions 
attended.
AREA COMPARED Statistical Result
AE vs. NU U= 133240.500, /?=0.496
AE vs. WG U= 31679.500, p=0.868
AE vs. ST U=25285.000, p=0.003
NU vs. WG U= 34974.00, /?=0.584
NU vs. ST U= 27605.500, /?=0.001
WG vs. ST U=6720.000, p=0.021
Significance level usedp< 0.00083, calculated using the bonferroni procedure
TABLE 2. Mann Whitnev-U Test Results: between referring agents and number o f sessions 
attended.
REFERRING AGENTS COMPARED Statistical Result
GP vs. CMHT U= 55101.000, p=0.174
GP vs. PMP U= 55744.000, /?=0.895
CMHT vs. PMP U= 6619.500, /?=0.236
Significance level used p<0.017, calculated using the bonferroni procedure
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Appendix 2.2: Article selection flowchart
Excluded by Title &  A bstract
excluded after examination of full article
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2 = Child Sample
9 = Neurosurgery = Not English
338 = Not relevant 
at all
92 = cardiac 
surgery
26 = Suitable Title & Abstract
13 = Non- 
systematic review
17 = editorials or 
letters
3 = Cognitive screen used to assess POCD
2 = No preoperative cognitive assessment
1 = No postoperative cognitive assessment
2 — General A not isolated or considered separately.
2 = No normal control group recruited
1 = Meta-analysis including all anaesthetic agents
2 = No formal cognitive assessment 
undertaken
2 = No immediate postoperative assessment 
prior to long term assessment with no control
5 = Older Adult population examined within 
general adult population
507 Titles and abstracts obtained 
using search strategy
8 Articles to be retained/included for 
systematic literature review




1. Evaluation Criteria Score
1.1 Does the study have a clearly 
focused question? 0 1
1.2 Does the study have explicit 
aims? 0 1
1.3 Are all the hypotheses stated?
0 1
2. Selection of Participants
2.1 Is the population defined?
0 1
2.2 Is the sample size stated?
0 1
2.3 Is the sample size justified by a 
power calculation? 0 1
2.4 Are the sample demographics 
stated? 0 1
I 2.5 Is the sample representative?
0 1
i 2.6 Are all the exclusion criteria 
I stated? 0 1
2.7 Are all the inclusion criteria 
stated? 0 1
2.8 Was a ‘normal’ non-surgical 
control group recruited? (to control for 
a learning effect on test performance)*
0 2
2.9 Are cases and controls taken from 
l comparable populations? 0 1
2.10 Are the same inclusion/exclusion 
criteria used for both cases and 
controls? 0 1
3. Procedures
3.1 Is there adequate randomisation of 
participants to interventions?
0 = inadequate (use of alternation, 
case record numbers, birth dates or 
week days etc)
1 = unclear or not stated
2 = adequate (computer generated 
random numbers or random 
number tables)
0 1 2
N ote criteria followed by a * denotes criteria taken from Statement o f Consensus (M urkin et al 1995; 1997). 155
3.2 Is there adequate blinding?
0 = inadequate (clinician aware of 
patient allocation)
1 = unclear or not stated
2 = adequate (clinician unaware of 
patient allocation).
0 1 2
3.3 Was the procedure replicable?
0 1
4. Assessment
4.1 Are outcome measures clearly 
defined? 0 1
4.2 Are outcome measures reliable?*
0 = none reliable
1 = some reliable
2 = most/all reliable
0 1 2
4.3 Are outcome measures sensitive?*
0 = none sensitive
1 = some sensitive
2 = most/all sensitive
0 1 2
4.4 If any assessment/outcome 
measures are not standardised or are 
adaptations of standardised 
assessments, have the reliability and 
validity statistics been stated? Have 
adaptations been adequately 
described?
0 = adaptations not stated or 
reliability/validity assessed
1 = unclear or not stated
2 = adaptations stated, statistics 
given, or no adapted assessments 
used.
0 1 2
: 4.5 Were parallel forms used between 
re-assessment sessions?*
; 0 = no
; 1 = some parallel forms/unclear 
2 = all parallel forms
0 1 2
; 4.6 Is the assessment of outcome 
i  blind to exposure status?*
| 0 =  inadequate (unblinded)
1 = unclear or not stated
2 = adequate
0 1 2
i  4.7 Is normative data available for 
I appropriate comparisons? 0 1
4.8 Was neurologic/neuropsychologic 
state assessed prior to surgery to 
obtain an accurate baseline?*
0 1
4.9 Were cognitive domains assessed 
balanced?* 0 1
4.10 Are tests free from sex, race, and 
ethnic bias and structured to avoid 
floor and ceiling effects?*
0 1
N ote criteria followed by a * denotes criteria taken from Statement o f Consensus (M urkin et al 1995; 1997). 156
4.11 Were participants assessed by 
the same qualified and suitable 
examiner between sessions?*
0 1
4.12 Was care taken to perform at 
least one assessment when 
performance is more stable (at least 3 
months postoperatively)*
0 1
4.13 Were subjects tested in a quiet, 
neutral environment to minimise 
distractions and interruptions?*
0 1
4.14 Were follow-up testing sessions 




5.1 Were most potential confounding 
demographic factors (e.g., age, sex 
etc) identified and considered in the 
design?
0 1
5.2 Was a mood assessment 
performed concurrently to control for 
mood influence on test performance?*
0 1
5.3 Were most potential confounding 
clinical factors (e.g., disease severity, 
vascular disease, duration of medical 
illnesses etc) identified and considered 
in the design?
0 1
5.4 Were most potential confounding 
demographic factors (e.g., age, sex 
etc) identified and considered in the 
analysis?
0 1
5.4 Were most potential confounding 
clinical factors (e.g., disease severity, 
i vascular disease, duration of medical 




6.1 Do the authors determine whether 
their groups are comparable and, if 
I necessary, adjust for baseline 
differences?
0 1
f 6.2 Are appropriate statistical tests 
[ used? 0 1
6.3 Are the results clearly stated?
0 1
6.4 Are confidence intervals provided?
0 1
6.5 Was a learning/practice effect 
controlled for? 0 1
Note criteria followed by a * denotes criteria taken from Statement of Consensus (Murkin et al 1995; 1997). 157
6.6 Is there an adequate description of 
withdrawals?
0 = inadequate or not stated (only 
numbers, not reasons stated)
1 = partially stated
2 = numbers and reasons provided for 
each group.
0 1 2
6.7 Is POCD identified in individuals 
using individual change scores rather 
than group means?*
0 1
7. Overall assessment of the study
7.1 How well was the study done to 
minimise the risk of bias or 
confounding, and to establish a causal 
relationship between exposure and 
effect?
0 = inadequate
1 = somewhat adequate
2 = adequate
0 1 2
7.2 Are the results of the study 
generalisable? 0 1
Total score (maximum = 54)
Overall %
Overall Grade
N ote criteria followed by a * denotes criteria taken from Statement o f Consensus (M urkin et al 1995; 1997). 158
Appendix 3.1: M ajor Research Project Proposal Guidelines
Major Research Proposal
This can be written in the form o f an application to a Local Research Ethics Committee 
and be presented, in full, in the final Research Portfolio. A copy o f the letter(s) o f ethical 
approval received from the LREC must also be included in the Research Portfolio. In 
circumstances where the completed project deviated from the original approved plan, the 
trainee must insert a clear explanation of these changes. Any further correspondence 
with the LREC, which relates to such changes must also be appended. The Major 
Research Project Proposal should include the following headings.
■ Full title o f project
■ Summary o f project
■ Introduction
■ Aims and hypotheses
o Aims 
o Hypotheses





o Design and Procedures
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N o r t h  G l a s g o w  U n iv e r s i ty  H o s p i ta ls  
D iv is ion
W e st E thics C om m ittee 
W estern  Infirmary 
D um barton  R oad  
G lasgow  G11 6NT
T e lep h o n e : 0141 211 6238  
Fax: 0 1 4 1 2 1 1 1 9 2 0
D ate  17lh Jan u a ry  2006  
O ur Ref: AHT/SAJ
Greater
Glasgow
E n q u ir ie s  to  A n d re a  T o rr ie  
E x te n s io n  A s a b o v e  
D ire c t L in e  A s  a b o v e
e -m a il  a d d r e s s :
A n d re a .  to r r ie @ n o r th q la s q o w . 
s c o t .n h s .u k
Ms Leigh Witnall-Pate 
Section of Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow
/  /-<. . ‘ . /V
Dear Ms Whiptall-Pate
Project: 05/S0709/131 Ms L Whitnall-Pate Psychological distress in disease-free 
breast cancer survivors completing tamoxifen therapy : the contribution of 
illness and treatment representations of psychological morbidity
The Committee at the meeting on 17m January 2006 noted and approved the content of 
letter from received 17th December 2005 from you enclosing Notice of Substantial 
Amendment for the above study
Yours sincerely,
7 V /u  . -
Andrea H Torrie
Manager -  West Ethics Committee
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Appendix 3.3: Ethical approval letter for substantial amendm ent 2
W est Ethics C om m ittee
North Glasgow University Hospitals 
Division
W estern  Infirmary 
D um barton R oad 
G lasgow  G11 6NT NHS
T elephone: 0141 211 6238 
Fax: 0141 211 1920 Greater
GlasgowD ate 21 *' F ebruary  2006 O ur Ref: AHT/SAJ
Enquiries to A ndrea Torrie 
Extension  As above
Direct Line As above
e-m ail ad d ress :
Andrea.torrie@ northqlasQ ow . 
scot.nhs.uk
Ms Leigh Whitnall-Pate 
Section of Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow
Project: 05/S0709/131 Psychological distress in disease-free breast cancer survivors 
completing tamoxifen therapy : the contribution of illness and treatment 
representations to psychological morbidity
The Committee noted and approved the content of letter dated 31st January 2006 from you 
enclosing a Notice of Substantial Amendment to the above study
Yours sincerely,
Andrea H Torrie
Manager -  West Ethics Committees
Appendix 4.1: Note for contributors to Psych-Oncology
For Authors 
Instructions to Authors
Manuscript Submission. Psycho-Oncology operates an online submission and peer review system 
that allows authors to submit articles online and track their progress via a web interface. Please read 
the remainder of these instructions to authors and then click http://mc.manuscriptcentral.com/pon to 
navigate to the Psycho-Oncology online submission site.
All papers must be submitted via the online system.
File types. Preferred formats for the text and tables o f your manuscript are .doc, .rtf, .ppt, .xls. 
LaTeX files may be submitted provided that an .eps or .pdf file is provided in addition to the source 
files. Figures may be provided in .tiff or .eps format.
Important information for authors using LaTeX. If you have used LaTeX to prepare your 
manuscript you should observe the following instructions:
• Initial submission: For reviewing purposes you should upload either an .eps, .pdf or .rtf 
created from your source files.
• Submission of a revised manuscript: When submitting your revision you must still upload 
an .eps, .pdf or .rtf for reviewing purposes. In addition you must upload your LaTeX source 
files. If your manuscript is accepted for publication we will use the files you upload to 
typeset your article within a totally digital workflow.
Authors must only supply by postal mail to the Editorial Office: a Copyright Transfer Agreement 
with original signature(s) - without this we are unable to accept the submission, and
• permission grants - if the manuscript contains extracts, including illustrations, from other 
copyright works (including material from on-line or intranet sources) it is the author's 
responsibility to obtain written permission from the owners o f the publishing rights to 
reproduce such extracts using the Wiley Permission Request Form.
The Copyright Transfer Form and the Permissions Form should be sent to the Content Editor. The 
forms must be sent immediately following the online submission of your article.
Content Editor - David Sheppard, John Wiley and Sons Ltd, The Atrium, Southern Gate, 
Chichester, West Sussex, P019 8SQ, UK.
Submission of a manuscript will be held to imply that it contains original unpublished work and is 
not being submitted for publication elsewhere at the same time. Submitted material will not be 
returned to the author, unless specifically requested.
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Manuscript Style. The language of the journal is English. All submissions including book reviews 
must have a title, and have a margin of 3cm all round. Illustrations and tables must be on separate 
sheets, and not be incorporated into the text.
• The title page must list the full title, short title o f up to 70 characters and names and 
affiliations of all authors. Give the full address, including email, telephone and fax, o f the 
author who is to check the proofs.
• Include the name(s) o f any sponsor(s) of the research contained in the paper, along with 
grant number(s).
• The current word limit for the journal is, for research articles, 5000 including figures and/or 
tables but excluding references. For brief reports the limit is 2000 words including no more 
than two tables or figures and no more than 20 references.
Supply a summary of up to 200 words for all articles [except book reviews]. A summary is a concise 
summary o f the whole paper, not just the conclusions, and is understandable without reference to the 
rest o f the paper. It should contain no citation to other published work.
All abbreviations except for SI symbols should be written in full the first time they appear. Generic 
or clinical names should be used for all compounds: materials and products should be identified. The 
species o f any animals used should be stated precisely. Sources of unusual materials and chemicals, 
and the manufacturer and model of equipment should be indicated. Materials and products should be 
identified in the text by the generic name followed by the trade name in brackets.
Reference Style. References should be quoted in the text as name and year within square brackets 
and listed at the end of the paper alphabetically. All references must be complete and accurate.
Where possible the D PI for the reference should be included at the end o f the reference. Online 
citations should include date o f access. Use MedLine abbreviations for journal names. They can be 
found at: http://www.ncbi.nlm.nih.gov/entrez/irbrowser.cgi. If necessary, cite unpublished or 
personal work in the text but do not include it in the reference list. References should be listed in the 
following style:
Harris CA, Zakowski SG. 2003. Comparisons of Distress in Adolescents o f Cancer Patients and 
Controls. Pyscho-Oncology 12:173-182. D01:10.1002/pon.631
Cox T, Cox S. 1983. The role o f adrenals on the psychophysiology of stress. In Current Issues in 
Clinical Psychology, Karas E. (ed). Plenum Press: London, 3-12.
Lazarus R. 1976. Patterns o f  Adjustment. McGraw-Hill: New York
Illustrations. Upload each figure as a separate file in either .tiff or .eps format, with the lead author's 
name, the figure number and the top o f the figure indicated. Compound figures e.g. la, b, c should 
be uploaded as one figure. Tints are not acceptable. Lettering must be of a reasonable size that would 
still be clearly legible upon reduction, and consistent within each figure and set o f figures. Where a 
key to symbols is required, please include this in the artwork itself, not in the figure legend. All 
illustrations must be supplied at the correct resolution:
• Black and white and colour photos - 300 dpi
• Graphs, drawings, etc - 800 dpi preferred; 600 dpi minimum
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• Combinations of photos and drawings (black and white and colour) - 500 dpi
Tables should be part of the main document and should be placed after the references. If the table is 
created in excel the file should be uploaded separately.
Colour illustrations will not be accepted.
C opyright. To enable the publisher to disseminate the author’s work to the fullest extent, the author 
must sign a Copyright Transfer Agreement, transferring copyright in the article from the author to 
the publisher, and submit the original signed agreement with the article presented for publication. A 
copy o f the agreement to be used (which may be photocopied) can be found in the first issue o f each 
volume of Psycho-Oncology. Copies may also be obtained from the journal editor or publisher, or 
may be printed from this website.
F u rth e r  Inform ation. Proofs will be sent to the author for checking. This stage is to be used only to 
correct errors that may have been introduced during the production process. Prompt return o f the 
corrected proofs, preferably within two days of receipt, will minimise the risk o f the paper being 
held over to a later issue. 25 complimentary offprints will be provided to the author who checked the 
proofs, unless otherwise indicated. Further offprints and copies o f the journal may be ordered. There 
is no page charge to authors.
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Appendix 4.2: Ethical approval letters from Greater Glasgow/North Glasgow Hospitals





West Glasgow Ethics Committee 2
W estern  Infirmary 
D um barton  R oad  
G lasgow  
G11 6NT
T elephone: 0141 211 6238  
Facsim ile: 0141 211 1920
Ms Leigh Whitnall-Pate 
Trainee Clinical Psychologist 
Greater Glasgow Primary Care NHS Trust 
Section of Psychological Medicine,
1055 Great Western Road 
Glasgow G12 0XH
• /  , - /  c - 7 L.
Dear Ms Wb!tnall-Pat6
Full title of study:
REC reference number:
Psychological distress in disease-free breast cancer 
survivors completing tamoxifen therapy: the contribution 
of illness and treatment representations to psychological 
morbidity.
05/S0709/131
The Research Ethics Committee reviewed the above application at the meeting held on 15 
November 2005. The Committee thanked you for attending the meeting to discuss your 
study.
The Committee discussed the undernoted with you:
Study design:
a) The Committee wondered if you would be present when the questionnaires are being 
completed - you replied that this would be the case.
b) The Committee were of the opinion that A10 re null hypotheses had been misunderstood 
and discussed this with you.
c) The Committee were of the opinion that the questionnaires should be piloted in patients 
as they thought that these would take "up to an hour" to complete andthat the submission 
and PIS should be amended appropriately.
d) The Committee thought that you should "pilot" the order of the questionnaires - it may not 
be appropriate to start with the "anxiety/distress” questionnaire
The Patient Information sheet should be amended as under:
a) GP does not in this instance require to be notified.
b) A further sentence or sentences should be added in respect of "being free not to answer 
all the questions or all of the questionnaires".
c) A further sentence should be added in bold to the effect that "taking part may actually 
raise some issues which you may previously have not considered".
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05/S0709/131 Page 2
d) Amend PIS to take into account the revised completion times.
The above minor amendments/clarifications should come back to the Secretary and 
Chairman for approval.
Ethical opinion
The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation.
Ethical review of research sites
The favourable opinion applies to the research sites listed on the attached form.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully.
Approved documents
The documents reviewed and approved at the meeting were:
Document Version Date
Application 5.0 31 October 2005
Investigator CV 31 October 2005
Investigator CV Summary (student) ' • 31 October 2005
Protocol 1 31 October 2005
Covering Letter 31 October 2005
Summary/Synopsis 31 October 2005
Peer Review 31 October 2005
Questionnaire 31 October 2005
Letter of invitation to participant
GP/Consultant Information Sheets 1 31 October 2005
Participant Information Sheet 1 31 October 2005
Participant Consent Form 1 31 October 2005
Research governance approval
The study should not commence at any NHS site until the local Principal Investigator has 
obtained final research governance approval from the R&D Department for the relevant NHS 
care organisation.
Membership of the Committee
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
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05/S0709/131 Page 3
05/S0709/131___________________ Please quote this number on all correspondence
With the Committee’s best wishes for the success of this project 
Yours sincerely
Andrea H Torrie
Ethics M anager-W est Ethics Committee
Email: andrea.torrie@northglasgow.scot.nhs.uk
Enclosures: List of names and professions of members who were present at the
meeting and those who submitted written comments 
Standard approval conditions SL-AC2 
Site approval form (SF1)
Copy to: R&D Department
Greater Glasgow Primary Care NHS Trust 
Research & Development Directorate 
G art navel Royal Hospital 
1055 Great Western Road, Glasgow
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West Glasgow Ethics Committee 2
W estern  Infirmary 
D um barton R oad 
G lasgow  
G11 6NT
T elephone: 0141 211 6238 




Greater Glasgow Primary Care NHS Trust
Section of Psychological Medicine, Academic Centre,
1055 Great Western Road
Glasgow G12 0XH
Dear Ms Whitnall-Pate 
Full title of study:
REC reference number:
The REC gave a favourable ethical opinion to this study on 15 November 2005.
Further notification(s) have been received from local site assessor(s) following site-specific 
assessment. On behalf of the Committee, I am pleased to confirm the extension of the 
favourable opinion to the new site(s). I attach an updated version of the site approval form, 
listing all sites with a favourable ethical opinion to conduct the research.
Research governance approval
The Chief Investigator or sponsor should inform the local Principal Investigator at each site of 
the favourable opinion by sending a copy of this letter and the attached form. The research 
should not commence at any NHS site until research governance approval from the relevant 
NHS care organisation has been confirmed.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating
Psychological distress in disease-free breast cancer 
survivors completing tamoxifen therapy: the contribution 





Procedures for Research Ethics Committees in the UK.
05/S0709/131_____________ Please quote this number on all correspondence
Yours sincerely
Mrs Andrea Torrie 
Committee Co-ordinator
Email: andrea.torrie@northglasgow.scot.nhs.uk
Enclosure: Site approval form
Copy to: Greater Glasgow Primary Care NHS Trust
Research & Development Directorate 
Gartnavel Royal Hospital 
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‘Patient attitudes associated with stopping tamoxifen treatment1
As you have been taking tamoxifen for over 4 Vi years and are about to attend the 
breast cancer clinic for a follow-up appointment at the Western Infirmary I am writing 
to ask if  you would consider participating in the above research study w hich is being 
carried out in the clinic.
I have enclosed an inform ation sheet detailing the background o f the study, what 
would be asked o f you if  you decide to take part, and other questions you may have 
about taking part in the study. The research study is being conducted by the Section 
o f Psychological M edicine at the University o f Glasgow.
If, after reading the information sheet, you are interested in taking part in the study, 
and I have discussed your participation with you at your clinic appointment the 
researcher will meet with you at the clinic after your follow-up consultation. Taking 
part will involve meeting the researcher for 20-30 minutes after your appointment on 
one occasion only. You can ask any questions regarding this study by telephoning the 
researcher Leigh W hitnall on 0779 505 5143 or by meeting her at the clinic before 
taking part. M eeting or speaking with the researcher will NOT commit you to taking 
part in the study.
I would like to take this opportunity to thank you for taking the time to read this letter. 
Yours sincerely
Professor W D George 




Appendix 4.4: Patient Inform ation Sheet
PATIENT INFORMATION SHEET
Study Title
Patient attitudes associated with stopping tamoxifen treatment.
Introduction
You are being invited to take part in a research study. Before you decide whether you want to take 
part it is important for you to understand why the research is being done and what it will involve. 
Please take time to read the following information and discuss it with friends or relatives. If you 
would like more information or there is anything that is not clear please ask us. Take time to decide 
whether or not you wish to take part.
Thank you for reading this information sheet.
What is the purpose of the study?
A large number of women diagnosed with breast cancer have been prescribed tamoxifen for a 
period of 5 years. It has been observed in some clinics that women vary in their attitudes to 
stopping tamoxifen treatment. The intention of our research is to examine various psychological 
factors to see if they explain variation in women’s attitudes.
Why have I been chosen?
This study is specifically looking at women that are about to stop taking tamoxifen, after taking it for
nearly five years. As you are due to attend the breast cancer clinic for your follow-up appointment
and have been taking tamoxifen for 4 1A years or more, you have been chosen to be invited to take 
part.
Do I have to take part?
No. It is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and asked to sign a consent form. If you decide to take part you 
are still free to withdraw at any time and without giving a reason. A decision to withdraw at any time, 
or a decision not to take part, will not affect the standard of care you receive.
What will happen to me if I take part?
During your clinic appointment the breast cancer surgeon will ask if you would like to take part in 
the study and if you have any questions about the study. If you are willing to take part you will meet 
with the researcher, Leigh Whitnall, after your clinic appointment in the next room. If you consent to 
taking part in the study you will be asked to fill in some questionnaires about your mood, 
personality, coping style, and beliefs about cancer and tamoxifen therapy. You will also be asked 
some questions about yourself and how you are, being free not to answer all the questions or all of 
the questionnaires. This should take approximately 20-30 minutes. Taking part may raise some 
issues, which you may previously not have considered.
PSYCHO LO GICAL M E D IC IN E  
Division of Community Based Sciences 




Head of Section of Psychological Medicine: Dr Elizabeth A Campbell
What are the possible benefits of taking part?
There are no direct benefits for you by taking part in this study. However, the information we get 
from this study may help us to understand better women’s varying attitudes to stopping tamoxifen.
Will my taking part in this study be kept confidential?
All information received will be completely confidential and known only to the research workers and 
names of patients will not be divulged to any other person without further consent. Your GP and 
breast cancer team will be notified of your participation, with your consent, in writing by the 
researcher. Any information about you that leaves the hospital will have your name and address 
removed so that you cannot be recognised from it and will be stored in locked filing cabinets.
What will happen to the results of the research study?
The researcher will write up the results of the research study. A summary of results can be 
provided to you if requested. You will not be identified in any reports or publications.
Who is organising and funding the research?
Leigh Whitnall, Trainee Clinical Psychologist and Professor Keith Millar from the Section of 
Psychological Medicine at Glasgow University together with Dr Sharon Mulhern, Clinical 
Psychologist, and Professor Craig White, Consultant Clinical Psychologist from the Cancer Distress 
Management Project in Ayrshire, are the organisers of the research. The study is funded by the 
Section of Psychological Medicine as part of the training requirements of Leigh Whitnall’s Doctorate 
in Clinical Psychology. If you agree to take part you will not incur any expense.
Contact for further information
If you have any questions about the study please contact Leigh Whitnall, Trainee Clinical 
Psychologist on 07795055142 or email Iw57j@clinmed.gla.ac.uk
Thank you for considering this invitation to participate in the research study.
Complaints
If you want to make a complaint regarding the receipt of this information, or its contents, you can 
telephone the Western Infirmary Complaints Officer on 0141 211 2257 or 0141 211 2926.
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Title of Project: Patient Attitudes associated with stopping Tamoxifen Treatment
Name of Researcher: Leigh Whitnall Please Initial Box
1. I confirm that I have read and understood the information sheet dated.......................
(version.........................) for the above study and have had the opportunity to
ask questions.
2. I understand that my participation is voluntary and that I am free to withdraw
at any time, without giving reason, without my medical care or legal rights being affected.
3. I give permission for the researcher to notify my General Practitioner and Breast 
Cancer Clinic team members that I am participating in this research.
4. I agree to take part in the above study.
Name of Patient Date Signature
Name of Person taking consent 
(if different from researcher)
Date Signature
Researcher Date Signature
PSYCHO LO GICAL M E D IC IN E  
Division of Community Based Sciences 
Academic Centre, Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow G12 OXH
Head of Section o f Psychological Medicine: Dr Elizabeth A Campbell
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Appendix 4.6: Fear of Recurrence Questionnaire 
Fear of Recurrence Questionnaire.
Check the answer which best typifies your response to the statement.
Strongly
agree
Agree Neutral Disagree Strongly
Disagree
1. I think about my health often.
2. I am bothered by the uncertainty o f  my 
health status.
3. I think more about my health now than 
before my cancer was diagnosed.
4. I have no physical concerns at this time.
5. I worry more about my health than other 
people worry about their health.
6. I feel that there is little need to worry 
about my future health status.
7. I always take my health into 
consideration when making future plans.
8. Compared to other persons who have 
cancer, I feel that I worry less than they do 
about health concerns.
9. My future health status is not a major 
concern o f mine.
10. I sometimes find myself preoccupied 
with my physical condition.
11. Just prior to regularly scheduled exams, 
my uneasiness about my health increases.
12. I think no more about my health 
presently than I did before my cancer was 
diagnosed.
13. I am not bothered by uncertainty 
regarding my health status.
14. I would like to feel more certain about 
my health.
15. I seldom think about my health.
16. Because o f my physical health, my 
future is o f concern to me.
17. I do not worry about my cancer 
returning.
18. When I think about my future health 
status, I feel some uneasiness.
19. Minor aches and pains remind me o f my 
cancer.
20. I feel optimistic as I focus on my future.
21. I am concerned that the difficulties with 
my cancer may not be over.
22. I do not feel anxious about my future 
when I read articles about my cancer.
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Appendix 4.7: Semi-structured questionnaire
Semi-structured interview to be carried out by chief investigator prior to completion of 
questionnaires.
Socio-Demographic Information
Participant ID Postal Code
DOB Age
Marital Status Single Separated No of children <21 yrs
(circle) Divorced Widowed
Married Other Live Alone? Yes / No
Treatment History
Treatment Received as part of treatment Date of procedure/ treatment 
completed
Lumpectomy Yes / No
Mastectomy Yes / No
Chemotherapy Yes / No
Radiotherapy Yes / No
Neoadjuvant/Endocrine Yes / No
Other Yes / No
Medical History
Significant medical history
(e.g., other advanced disease, chronic
illness, hospitalisations)
Yes / No
If yes, please state more detail.
Significant psychiatric history (e.g., 
history of anxiety, depression, Bipolar 
disorder, or psychosis that was treated 
by medication or talking therapy.
Yes / No
If yes, please state more detail.
History of alcohol/substance abuse Yes / No
Current alcohol/substance abuse Yes / No
Response to Completing Tamoxifen
How would you describe how you feel about coming off Tamoxifen in the next 6 months?
Apprehensive Not at all A Little Some A lot
Relief Not at all A Little Some A lot
Anxious Not at all A Little Some A lot
Positive Not at all A Little Some A lot
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Have you taken tamoxifen as prescribed by your surgeon i.e., have you taken it as per their 
advice during the last 4.5 years? Yes / No 
If no, please state why:
Have there been times where you did not take tamoxifen? Yes I  No 
If yes, please state why-
